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The basic helix-loop-helix PAS domain transcription factor gene NPAS3 is a risk 
factor for psychiatric disorders. A knockout mouse model also exhibits behavioural 
and adult neurogenesis deficits consistent with human illness. To define the location 
and mechanism of NPAS3 aetiopathology immunofluorescent and transcriptomic 
approaches were used. 
 
Npas3 was co-localised with Dcx, but not other neurogenesis markers, in the 
hippocampal subgranular zone - the site of adult neurogenesis. This implied that 
NPAS3 might be involved in maturing, rather than proliferating, neuronal precursor 
cells. Microarray analysis revealed that the transcriptional activities of NPAS3 and 
its truncated form (C-terminal deletion) in the HEK293 cell line are sensitive to 
circadian rhythm context. The most highly up-regulated NPAS3 target gene, VGF, 
encodes secretory peptides with established roles in neurogenesis, depression and 
schizophrenia. VGF was one of many NPAS3 target genes also shown to be 
regulated by the SOX family of transcription factors, suggesting an overlap in 
neurodevelopmental pathways. The transcriptional repression of multiple glycolytic 
genes indicated that NPAS3 has a second role in metabolic regulation. This finding 
was also confirmed by collaboration with a metabolomics research group at the 
University of Strathclyde.  
 
SOX11, a transcription factor known to play a role in neuronal and glial cell 
differentiation, was shown to be down-regulated by NPAS3. The set of genes 
targeted by SOX11 and their ontologies were deduced by a microarray analysis in a 
 viii 
SOX11 overexpressing HEK293 cell line. Regulated genes include a previously 
established SOX11 target, known markers of neurogenesis as well as genes 
implicated in neuropsychiatric disorders. Multiple histone and zinc finger genes are 
regulated by SOX11, many of which were located in two clusters on chromosomes 6 
and 19. The chromosome 6 cluster lies within a region of the genome showing the 
strongest genetic association with schizophrenia. SOX11 may alter localised 
expression competence and its targets induce a complex programme of chromatin 
remodelling and downstream gene expression changes to achieve the mature 
neuronal phenotype.  
 
This thesis details how transcription factors are involved in biological processes 
linked to psychiatric illness. The dual neurodevelopmental and metabolic aspects of 
NPAS3 activity described here increase our understanding of aspects of neurogenesis 
relevant to mental illness and may explain the innate and medication-induced 
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1.1 Psychiatric illnesses 
1.1.1 Schizophrenia 
Schizophrenia, which affects about 4-6 in a thousand individuals (Bhugra, 2005; 
Goldner et al., 2002), is a neuropsychiatric disorder characterised by abnormalities in 
a person’s thinking, mood, movement, and perceptions. Schizophrenia is described in 
terms of positive and negative symptoms. In the acute phases of illness, a person 
often presents with positive symptoms. Typically a person may become very 
distressed and agitated, express delusional beliefs and may experience hallucinations 
in the form of voices, smells or experience of touch and usually require treatment in 
hospital. Anti-psychotic medication is very effective at controlling these positive 
symptoms. To prevent relapse, long-term medication may be required and patients 
rarely return to their previous level of function. Negative symptoms include apathy, 
poverty of speech, inability to experience pleasure, lack of desire to form 
relationships and psychological deficits in executive function and episodic memory. 
A person with negative symptoms is often withdrawn without drive, ambition and 
goal-directed behaviour. They may appear and sound emotionally ‘flat’. Speech may 
be slowed and show evidence of unusual words and grammar. Repetitive body 
movements are common. These symptoms do not respond well to medication. Thus a 
person with chronic schizophrenia has many difficulties affecting all aspects of life. 
 
The cognitive deficits in schizophrenia include excessive attention to potential 
threats, jumping to conclusions, impaired reasoning about social situation and mental 
states etc. (Broome et al., 2005; Brune et al., 2007; Lewis, 2004; Sitskoorn et al., 
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2004). Some neurocognitive deficits are related to issues in memory, attention, 
problem-solving, executive function and social cognition (Kurtz, 2005). 
 
The peak years for the onset of symptoms are typically late adolescence and early 
adulthood in males and females (the mean age of onset is 20–28 years for males and 
26–32 years for females). Increased physical health problems and higher self-
harming and suicide rate are the main reasons which reduce the life expectancy of 
schizophrenia patients by 10-12 years compared to the healthy population (Brown et 
al., 2000; Palmer et al., 2005). It incurs high public health cost and results in a poor 
quality of life and has a devastating impact on societies across the whole world.   
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1.1.1.1 Factors which can contribute to schizophrenia 
It is clear that a full explanation of schizophrenia must take account of both genetic 
and environmental influences. (Corcoran et al., 2003; Harrison and Owen, 2003). It 
is very difficult to separate the effects of genetic and environmental factors in the 
heritability of schizophrenia, although twin and adoption studies have suggested a 
high level of heritability. 
 
The environmental factors which contribute the disease include: hypoxia at birth, 
migration, living in a city, season of birth (winter has a higher risk for schizophrenia), 
cannabis, starvation etc. Fetal Hypoxia has been supported as an important external 
factor that influences the susceptibility of schizophrenia (Handford, 1975). In 
numerous studies, fetal hypoxia has been correlated with neuronal dysfunction and 
subtle damage (Rosso et al., 2000; Van Erp et al., 2002). Normal embryonic and fetal 
hypoxia or pathological hypoxia may affect neurodevelopment by regulating several 
genes. Schmidt-Kastner et al. reviewed that more than 50% of the schizophrenia 
candidate genes met criteria for ischemia-hypoxia regulation (Schmidt-Kastner et al., 
2006). Cannon et al. found that obstetric complications involving hypoxia were 
associated with neurodevelopmental impairments in childhood and with the later 
development of schizophreniform disorders through a longitudinal study (Cannon et 
al., 2002). A study of Japanese monozygotic twins discordant for schizophrenia (one 
has the diagnosis while the other does not) suggests that hypoxic brain damage 
maybe a differentiation factor for the abnormalities in psychosocial development and 
subsequent schizophrenia (Kunugi et al., 2003). Although hypoxic impairment does 
not account for all schizophrenia cases, it is very possibly that prenatal and perinatal 
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hypoxia play an important role in the neurodevelopment and subsequent 
development of schizophrenia, which suggests that some forms of schizophrenia may 
be preventable (Marin et al., 1991).  
 
Schizophrenia is a condition of complex inheritance with many different major or 
minor genes increasing risk. Adoption studies showed increased risk in those raised 
in normal environment but with schizophrenic biological parents. These studies 
suggest that schizophrenic phenotype is genetically influenced. Individual twin 
studies and meta-analyses of twin studies estimate that schizophrenia is a 
heterogeneous syndrome with a heritability score of approximately 0.8 (Huntley et 
al., 2003). (This refers to the proportion of variation between individuals in a 
population that is influenced by genetic factors, not the degree of genetic 
determination of individual risk). Concordance rates of schizophrenia are about 50% 
in monozygotic twins and 17% between dizygotic twins. There is still limitation in 
the methodology of the twin studies. Although the concordance of schizophrenia in 
monozygotic twins has traditionally been used to estimate a genetic component, the 
result could be skewed due to the environmental factors (including shared placenta 
etc.) (Davis et al., 1995). 
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1.1.1.2 Traditional hypotheses based on neuropharmacology 
1.1.1.2.1 Dopamine hypothesis of schizophrenia 
Much evidence supports the hypothesis that a malfunction in the dopamine pathway 
is involved in the pathology of schizophrenia.  
 
Post-mortem studies have revealed elevated D2 receptors are present in untreated 
schizophrenia patients (Abi-Dargham et al., 2000; Abi-Dargham et al., 2009; Seeman 
and Kapur, 2000; Wong et al., 1986).  After large and prolonged use of amphetamine 
and cocaine, which increase levels of dopamine in the brain, these drugs can produce 
symptoms indistinguishable from those present in psychosis. The majority of 
schizophrenia patients (up to 75%) also have increased symptoms after treatment 
with moderate doses of methylphenidate or amphetamine or other dopamine-like 
compounds, while healthy controls do not have any psychologically disturbing 
effects (Curran et al., 2004; Lieberman et al., 1987). Several studies also show that 
schizophrenia patients have greater levels of dopamine release than normal 
individuals after amphetamine treatment. 
 
Another important piece of evidence is the observation that several antipsychotic 
drugs, including chlorpromazine and haloperidol, can antagonize dopamine binding 
to the D2 dopamine receptors and thus reduce positive symptoms (Creese et al., 1976; 
Seeman et al., 1976). There is also genetic evidence which supports the dopamine 
hypothesis of schizophrenia. Several genes or specific variants of genes, which relate 
to dopamine function, are more prevalent in schizophrenia patients than normal 
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population. These include COMT, DRD4 and AKT1 (Arguello and Gogos, 2008). 
However, the dopamine hypothesis can not be posited as a complete explanation for 
schizophrenia.  
1.1.1.2.2 Glutamate hypothesis of schizophrenia  
This hypothesis has also been supported by several lines of evidence. The first one is 
that abnormally low levels of NMDA glutamate receptors are found in post-mortem 
brains of schizophrenia patients (Halene et al., 2009; Konradi and Heckers, 2003). 
Additional evidence is that some mind-altering drugs such as phencyclidine and 
ketamine, which are glutamate blocking drugs, can produce the symptoms and 
cognitive problems similar to the condition of schizophrenia (Lahti et al., 2001). 
Finally, glutamatergic drugs, which can coagonistically act at the NMDA or non-
NMDA receptors, can reduce some of the positive symptoms of schizophrenia 
(Tuominen et al., 2005). NMDA receptor Grin1 (-/-) mice have a disinhibition in 
sensory processing and reduced behavioral inhibition and impaired social 
interactions. Impaired NMDAR function is possibly relevant to the negative 
symptoms in schizophrenia (Boulay et al., 2010; Halene et al., 2009; Ramsey, 2009). 
This hypothesis does not negate the dopamine hypothesis. These two hypotheses 
possibly function together by circuit-based models (Lisman et al., 2008). 
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1.1.1.2.3 Serotonin and schizophrenia 
Serotonin, also called 5-Hydroxytryptamine (5-HT), is a monoamine 
neurotransmitter, which is active in the gastrointestinal tract, platelets, and central 
nervous system (CNS) of humans and animals. The serotonin synthesized in 
serotonergic neurons in the CNS can regulate various types of processes, including 
mood, appetite, sleep, muscle contraction, and has cognitive functions, including 
memory and learning. Individuals with depression usually have lower levels of 
dopamine and serotonin in the brain (Meltzer and Sumiyoshi, 2008; Slowik, 1967). 
Several types of antidepressant medicines act through modulation of serotonin at 
synapses (Marino and Caballero, 2010; Wong et al., 2010). For instance, selective 
serotonin reuptake inhibitors (SSRIs) are typical antidepressants to treat depression, 
anxiety disorders and some personality disorders. SSRIs could inhibit the reuptake of 
serotonin into the presynaptic cell, increasing the extracellular level of serotonin. 
SSRI was reported to increase the level of brain derived neurotrophic factor (BDNF) 
through cAMP signal pathways on the postpsynaptic neuronal cell. Therefore, the 
growth and survival of cortical neurons and synapses are enhanced (Rumajogee et al., 
2004) 
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1.1.1.3 Abnormal brain structure in schizophrenia patients 
Brain imaging technologies and neuropsychological tests (including CT, MRI and 
PET) have produced a lot of extensive and precise findings on the deviation of brain 
function and structure in schizophrenia patients. Magnetic resonance imaging (MRI) 
can measure the volumes of anatomical structure and distinguish gray and white 
matter abnormalities. It was identified that functional differences in brain activity are 
usually occur in the frontal lobes, hippocampus and temporal lobes (Kircher and 
Thienel, 2005), which are linked to the neurocognitive deficits in schizophrenia 
(Green, 2006). 
 
The size and structure of certain brain areas in schizophrenia patients are also found 
different from healthy individuals, including lateral ventricular enlargement, gray 
and white matter reduction (Colter et al., 1987), loss of normal asymmetries, frontal, 
volume reduction in temporal total and superior temporal gyrus etc (Schlaepfer et al., 
1994). The reduced whole brain and hippocampal volume and increased ventricular 
volume in patients with a first psychotic episode have been found in a meta-analysis 
of MRI studies (Steen et al., 2006). 
 
It is possible that the brain volume change is due to weight gain and changes in the 
physiological balance and general hydration of an individual (Wenz et al., 1994). But 
it can not be ruled out that some of the brain volume changes, particularly in the 
early stage of illness, may be epiphenomena. 
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1.1.1.4 Medication treatment for Schizophrenia 
Medication treatment is used to control acute psychotic symptoms and to prevent 
relapse in the longer-term. Antipsychotic drugs are popularly used in the treatment of 
schizophrenia and bipolar disorders.  
 
There are older (typical) and newer (atypical) antipsychotics. Typical antipsychotics, 
including chlorpromazine, thioridazine, fluphenazine, haloperidol, flupenthioxl and 
pimozide are classified according to their different chemical structures and were 
designed to work by blocking dopamine at synapses in the brain. The typical 
antipsychotics tend to be associated with many unwanted side-effects such as 
trembling, rigidity, abnormal face and body movements, restlessness and abnormal 
insulin absorption. Many of these side-effects are dose related. Newer (atypical) 
psychotics tend to act in a different way (affecting different chemical messengers, 
such as serotonin) and are less likely to cause side-effects and can help negative 
symptoms. 
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1.1.2 Bipolar disorders 
Bipolar disorder or manic-depression is one of the most highly heritable psychiatric 
diagnoses and describes a category of mood disorders with abnormally elevated 
(manic and hypomanic) and abnormally depressed states or mixed episodes for a 
period of time. Bipolar disorder is sometimes accompanied by hallucinations, 
delusions and cognitive changes.  
 
Bipolar disorder is equally prevalent in males and females, and across all cultures 
and ethnic groups (Jamison, 1990). It is often difficult to diagnose as not everyone’s 
symptoms are the same and no blood test can confirm this disorder. In some cases, 
bipolar disorder is a devasting and long-lasting illness, especially during depressive 
episodes, as its episodes of abnormality are associated with distress and disruption 
and a higher risk of suicide than normal population (Goldberg and Harrow, 2004; 
Kessler et al., 2006a). Because relapse of bipolar disorder is very common, and this 
disorder can be profoundly disabling, the personal and societal cost of bipolar 
disorder are enormous (Kessler et al., 2006b). The onset of bipolar disorder generally 
occurs in late adolescence or early adulthood. 
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1.1.2.1 The genetics of Bipolar disorder 
The overall heritability of the bipolar spectrum is estimated at 0.71 (Edvardsen et al., 
2008). It was reported that the risk of bipolar disorder in first-degree relatives of 
bipolar disorder patients is approximately 9%, nearly 10 times that of the general 
population. The genetic causes are complex and multifactorial, due to many genes 
with individually small effect (Serretti and Mandelli, 2008). Twin studies have 
indicated that both genetic and environmental factors influence bipolar disorders. For 
bipolar I, the concordance rates are around 40% in monozygotic twins compared to 
4.5% to 5.6% in dizygotic twins (Kieseppa et al., 2004). The concordance rates of 
combination of bipolar I, II and cyclothymia is 42% in monozygotic twins, while 
11% in dizygotic twins. Since the concordance in monozygotic twins is not 100%, 
genetic factors are very important but can not be sufficient for bipolar disorder. 
 
A large number of candidate genes have been evaluated by gene-finding research, 
especially association studies. Until recently, efforts to identify specific susceptibility 
variants have been restricted to studies of biological and positional candidate genes. 
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1.1.2.2 Medication treatment for Bipolar disorders 
For bipolar disorders, Lithium carbonate, sodium valproate or lamotrigine are widely 
used mood stabilizer medications (Bauer and Mitchner, 2004; Geddes et al., 2004).  
Lithium is the only known mood stabilizer which can reduce suicide in bipolar 
patients. Lamotrigine is shown to be of benefit to prevent depression (Calabrese et al., 
1999). Carbamazepine is also widely used to treat rapid cycling bipolar disorder. 
However, the mode of action is not well understood. 
 
1.1.2.3 Abnormal brain structure in bipolar disorder patients 
Anatomical differences in amygdala, prefrontal cortex and hippocampus are found in 
the brains of bipolar and other mood disorders patients. A meta-analysis based on 98 
MRI or CT imaging studies found that the lateral ventricles in bipolar disorder 
patients were on average 17% larger than healthy controls, and the ratios of having 
deep white matter hyperintensities were 2.5 times of controls. 
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1.1.2.4 Circadian rhythm and bipolar disorder 
The human circadian rhythm is a roughly 24-hour endogenous cycle in biochemical, 
physiological or behavioural processes. The primary circadian clock in human is 
found in the suprachiasmatic nucleus (SCN) in the hypothalamus. SCN receives 
daylight information through the eyes and passes it on to the pineal gland. This 
process results in the hormone melatonin secretion. Dysfunction of SCN will result 
in an irregular wake-sleep rhythm. Other organs and cells, such as lungs, liver, 
pancreas, spleen, thymus and skin, also have circadian rhythms (Zanello et al., 2000).  
Disruption of circadian rhythm in humans is usually associated with a number of 
disorders such as bipolar disorder and sleep disorder (Harvey, 2008; McClung, 2007). 
It was reported that sleep deprivation can alleviate depression and regulate mood in 
bipolar disorders (Fahndrich, 1981; Larsen et al., 1976; Wehr et al., 1982). Circadian 
rhythm disturbances of bipolar disorder patients can be positively affected by lithium 
through an effect on clock genes (Martino et al., 2008). Lithium and valproate, which 
are effective medicine for bipolar disorders, also alter circadian rhythm in human and 
other species (Dokucu et al., 2005; Hafen and Wollnik, 1994; Johnsson et al., 1983). 
Dopaminergic (Ashby et al., 1999; Barbano and Cador, 2007; Lima et al., 2008; 
Yuferov et al., 2005) and serotonergic pathways (Adrien, 2002; Brummett et al., 
2007; Sprouse et al., 2006; Yuan et al., 2005) are critical in the link between 
circadian rhythm and emotion. But, unfortunately, there is little research on the 
integration of the circadian rhythm and neurotransmitter systems to psychiatric 
disorders. Several bipolar disorder candidate genes are involved in circadian rhythms, 
including the CLOCK and BMAL1 genes (Benedetti et al., 2003; Mansour et al., 2006; 
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Nievergelt et al., 2006; Serretti et al., 2003; Shi et al., 2008). Decreased levels of 
CRY2 were found in bipolar patients in a depressive state (Sjoholm et al., 2010). 
CRY2 participates in the core clock to regulate circadian rhythm and responds to 
total sleep deprivation (Takahashi et al., 2008). Taken together, circadian rhythm 




1.2 Molecular approaches to the study of psychiatric disorders 
As schizophrenia and bipolar disorder are highly heritable diseases, identification of 
the genetic factors which affect the risk of psychiatric disorders are very significant 
and necessary. These genetic factors have been partially revealed by new 
technological developments. These technological changes include linkage studies, 
association methodologies, genome-wide approaches (a form of association), copy 
number variation studies, and gene expression microarray studies. The knowledge 
derived from each of these approaches is summarized here. 
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1.2.1 Linkage studies 
Linkage studies are suitable for detecting markers spread across the genome of 
family members who are affected and unaffected with the disorder. The linkage 
studies can be applied to determine the chromosomal regions where susceptibility 
genes are located by examining a few hundred or thousand markers spread across the 
genome through detecting which markers (or regions) appear to be coinherited with 
disease within the family (Badner and Gershon 2002; Segurado, Detera-Wadleigh et 
al. 2003; McQueen, Devlin et al. 2005) Linkage studies are performed with single 
large families, collections of many smaller families and with two or more affected 
members. Many linkage studies were done with large numbers of affected sibling 
pairs. An advantage of linkage is that it can detect rare and common alleles. A 
disadvantage is that the region of linkage is large covering several mega bases and 
containing many genes. It does not allow the detection of individual candidate genes. 
The success of linkage studies in psychiatric disorders has been limited as linkage 
studies only work well in determining the single-gene Mendelian disorders (such as 
Huntington disease and Cystic fibrosis) or disorders in which genetic risk is 
conferred by a relatively small number of genes. These further support the 
hypotheses that psychiatric disorders are genetically complex diseases which are 
determined by a large number of genes, each of the susceptibility genes has a 
relatively small effect on disease risk. The linkage study works well on a large family 
with a major effect gene, but when comparing linkage data between families, it is not 
accurate due to heterogeneity. 
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1.2.2 Association studies 
Association studies typically examine susceptibility variants that are relatively 
common in the population. The specific variants can include a number of different 
types of variation, including single nucleotide polymorphisms (SNPs) and repeat 
polymorphisms. Over the past 10 years, genetic association studies have found many 
specific alleles which are more common in affected individuals than in matched 
controls (case-control studies) and specific variants which are transmitted from 
parents to affected individuals more often than expected by chance (family-based 
studies). The markers are selected based on positional evidence from linkage studies 
and/or from hypotheses about the underlying neurobiology of the disorder. 
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1.2.3 Genome-wide association studies (GWAS) 
Common genetic variation across the entire genome can be surveyed using 
microarray chips that simultaneously assay more than 1 million SNPs which match 
the complement of common variants. Thus, GWAS is a new and better approach to 
identify susceptibility genes without any prior hypothesis. This approach has been 
successfully used in the research of a broad range of complex disorders, including 
diabetes, breast cancer, cardiovascular disease, inflammatory bowel disease etc. A 
few groups carried out smaller GWAS studies, but in 2009, in order to fully take 
advantage of the technique, the psychiatric GWAS Consortium, a collaborative 
consortium, was been formed to look at many samples over many disorders 
(including bipolar disorder). 
 
GWAS is suited to a particular type of genetic effect, which is modest in size but 
with a risk allele frequency that is relatively common in the general population 
(Newton-Cheh and Hirschhorn, 2005). GWAS can also detect copy number variants, 
duplications and deletions, which have been reported for psychiatric disorders. The 
exceptional success of GWAS for complex disease has produced numerous 








1.2.4 Copy-number variations 
A copy-number variant (CNV) is a DNA segment, usually 1 kilobase to several 
megabases, with different copy numbers in comparison the normal diploid state of 
the genome. In humans, CNVs are a widespread and common phenomenon which 
can be caused by genomic rearrangements such as deletions, duplications, inversions 
and translocations. For example, for normal DNA sequence (parental copies), the 
copy number is 2, but recently it was found that a proportion of our DNA was 1 
(deletion) or 3 (duplication). This seems to be another form of genetic variation 
alongside SNPs. Although much copy number variation is common, the rare ones 
that alter gene dosage seem to be linked with illness. CNVs may be inherited or due 
to de novo mutation. Several techniques have been used to discover CNVs, including 














1.2.5 Gene expression Microarray analysis—High-throughput 
approaches to study gene expression 
Numerous susceptibility genes for psychiatric disorders have been discovered by the 
approaches discussed above, including novel genes for which a contribution to 
disease was unknown previously. Microarray analysis is very good at discovering the 
roles and regulatory profiles of a gene defect or a condition. A microarray contains 
tens of thousands of gene probes and can measure their expression simultaneously. 
As advances in gene annotations progress, standardization of microarray platforms 
and data analysis have been introduced. Microarrays are now an ideal approach to 
determine the changes in transcription of the genome in response to disease status 
(e.g., schizophrenia brain vs. healthy control brain), specific drug treatments, or as a 
consequence of mutations of psychiatric illnesses candidate genes in cell or animal 
models. These approaches can discover relevant target genes, canonical pathways 
and further generate new hypotheses. It is very necessary to confirm the key data by 
independent technologies, such as real-time quantitative PCR, in situ hybridization, 
immunoblots and other appropriate methods. It must be remembered that microarrays 
detect changes in the mRNA level which might not necessarily be translated into 







1.2.6 Candidate genes and chromosome regions associated with 
schizophrenia identified by these approaches 
Several detailed mapping studies based on positive linkage findings have identified 
several putative susceptibility genes for schizophrenia, such as genes encoding 
dysbindin (DTNBP1) (Schwab et al., 2003; Straub et al., 2002; van den Oord et al., 
2003; Williams et al., 2004), neuregulin 1 (NRG1) (Corvin et al., 2004; Stefansson et 
al., 2003; Yang et al., 2003), D-aminao-acide oxidase (DAO), D-amino-acid oxidase 
activator (DAOA or G72) and regulator of G-protein signalling 4 (RGS4) (Kirov et al., 
2004). The U2AF homology motif (UHM) kinase 1 (UHMK1) on the chromosome 
1q23.3 was previous reported as a schizophrenia susceptibility gene (16978587) and 
the genetic association between this gene and schizophrenia has been further 
confirmed in a fine-mapping study (Puri et al., 2008). 
 
Many hundreds of genes have been identified by association analysis. These genes 
include disrupted in schizophrenia (DISC1), the dopamine receptor (SLC6A3), brain-
derived neurotrophic factor (BDNF), the NMDA glutamate receptor submit 2B 
(GRIN2B), d-amino-acid oxidase activator (DAOA), peroxisome proliferators-
activated receptor delta (PPARD), neurogulin 1 (NRG1), the 5-HT transporter 
(SLC6A4), tryptophan hygroxylase-2 (TPH2), pericentriolar material 1 (PCM1) and 
catechol-o-methyl transferase (COMT) (Cardno and McGuffin, 2006; Craddock and 
Forty, 2006; De Luca et al., 2005; Fallin et al., 2005; Fan and Sklar, 2008); (Bass et 
al., 2009); (Datta et al., 2010; Gurling et al., 2006).  
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A susceptibility locus in an intron of ZNF804A (zinc finer protein 804A) is with a 
genome-wide significance (p=9.96 x10-9) (O'Donovan et al., 2009; Williams et al., 
2010). This gene encodes a transcription factor, which is associated with the 
activities of hippocampus and dorso-lateral prefrontal cortex (Esslinger et al., 2009). 
Shifman and colleagues found a strong evidence for a female-specific association 
between reelin and schizophrenia (Birkhofer et al., 2007; Shifman et al., 2008). 
Reelin has been reported having a reduced expression in the brain of schizophrenia 
patients (Knable et al., 2001) and being involved in corticogenesis and implicated in 
an autosomal recessive form of lissencephaly (Hong et al., 2000). 
 
Like other type of genetic variations, CNVs have been associated with autism, 
schizophrenia and idiopathic learning disability. 22q11DEL is reported to be 
associated with a 25-fold increase in the risk of schizophrenia (Bassett et al., 2008; 
Murphy et al., 1999). Deletions mapping to 1q21.1 and 15q13.3, which are 
associated with schizophrenia, were discovered in two CNV studies: the ISC one 
(ISC, 2008) and the one lead by decode genetics (Stefansson et al., 2008). Deletions 
at 1q21 not only increase risk of schizophrenia but were also associated with mental 
retardation, autism and ADHD (Mefford et al., 2008). Deletions at 15q13.3 are also 
involved in Idiopathic Generalized Epilepsy (Helbig et al., 2009). There are other 
CNV loci that are with strong statistical evidence for association such as 2p16.3 
(Del), 15q11.2 (Del), 16p13.1 (Dup), 16p11.2 (Dup)(McCarthy et al., 2009) and 
17p12 (del) etc. Although it cannot be denied that CNVs are involved in 
schizophrenia, the individual genes relevant to disease pathophysiology are still 
uncertain, as the implicated CNVs span multiple genes.  
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There are numerous findings in schizophrenia using gene expression microarray 
technology. Genes involved in the regulation of presynaptic function are found 
decreased in the prefrontal cortex of schizophrenia patients (Mirnics et al., 2000), 
which can explain the brain imaging observation that reduced activation of the 
prefrontal cortex during tasks engage working memory (Carter et al., 1998; Heckers 
et al., 1999; Petronis, 2003). Reduction in gene expression involved in metabolic 
pathways and ubiquitin degradation are found in prefrontal cortex in schizophrenia 
(Middleton et al., 2002; Vawter et al., 2002). Decreased ionotropic glutamate 
receptor (AMPA) (Vawter et al., 2002), oligodendrocyte specific transcripts (Hakak 
et al., 2001; Tkachev et al., 2003) and ubiquitin conjugating enzyme E2N were also 
found in schizophrenia using expression microarrays. Increased transcripts of the 
apolipoprotein L family genes, which are located close to a genetic high-
susceptibility locus for schizophrenia and velocardiofacial syndrome (an illness with 
schizophrenia-like features) on chromosome 22, were found in the brains of 
schizophrenia patients (Coon et al., 1994; Karayiorgou et al., 1995; Mimmack et al., 









1.2.7 Candidate genes and chromosome regions associated with 
bipolar disorders identified by these approaches 
McQueen et al. combined 11 of the largest linkage studies for bipolar disorder and 
found that chromosome 6q and 8q met statistical criteria for genome-wide 
significance (McQueen et al., 2005). TRPM2 and C21ORF29 (TSPEAR) on 
chromosome 21q22.3 were found associated with bipolar and unipolar affective 
disorder by a fine mapping study (McQuillin et al., 2006; Xu et al., 2009; Xu et al., 
2006).  
 
There have been several independent published GWAS of bipolar disorder based on 
individual genotyping or DNA pooling. A significant locus in DGKH (diacylglycerol 
kinase eta) was detected in a sample of 1,233 cases and 1,439 controls (Baum et al., 
2008). Diacylglycerol kinases are very important in a series of signalling pathways 
including a phosphatidyl insositol pathway, which is sensitive to lithium.  A genome 
wide significant association (P = 6.3 × 10 -8) for a locus on chromosome 16p2 was 
obtained in a GWAS based on 1,868 cases and 2,938 control (WTCCC 2007). This 
region spans several genes including PALB2 (partner and localizer of the breast 
cancer gene, BRCA2), NDUFAB1 (NADH dehydrogenase (ubiquinone) 1, alpha/beta) 
and DCTN5 (dynactin 5).  The strongest finding (P =1.7 × 10 -7) in MYO5B (myosin 
5B) was observed in another GWAS study, known as STEP-UCL, based on 1,461 
cases and 2,008 controls, although it did not pass the threshold of the genome wide 
significance (Sklar et al., 2008). A meta-analysis comprising the WTCCC, STEP-
UCL GWAS datasets and a supplemental GWAS data identified two associations 
with genome-wide significance: ANK3 (P =9.1 × 10 -9) and CACNA1C (calcium 
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channel, voltage-dependent, L type, alpha 1 C subunit) (P =7.0 × 10 -8) (Ferreira et 
al., 2008). ANK3 links integral membrane proteins to the underlying spectrin-actin 
cytoskeleton and is involved in cell motility, activation, proliferation, contact, and 
modulation of the activity of neuronal sodium channels. CACNA1C is a subunit of 
brain L-type voltage gated calcium channels and is responsive to synaptic activity 
(Vacher et al., 2008). 
 
For bipolar disorders, gene expression microarray studies found that reduced 
oligodendrocytes in the cortex (Tkachev et al., 2003) and reduced expression of the 
mitochondrial respiratory chain, which suggests abnormal energy regulation in the 
brain of bipolar patients (Kato and Kato, 2000; Kato et al., 1992). Down-regulation 
of proteasomal subunits in the hippocampus was also identified in bipolar disorder 
using gene expression microarray studies (Konradi et al., 2004). McQuillin and 
colleagues performed a microarray study the mRNA change in the mice brain after 
treated by lithium, a widely used mood stabilizer for bipolar. They found that period 
gene 2 (Per2), metabotropic glutamate receptor (Grm3) and secretogranin II (Scg2) 
as well as several myelin-related genes and protein phosphatases show significant 





1.2.8 Overlapping findings associated with both schizophrenia and 
bipolar disorders 
Although bipolar disorder and schizophrenia were assumed to be separate disease 
entities, genetic linkage studies have identified some chromosome overlapping 
regions associated with both disorders. These include regions in 13q, 22q, 6p, 4p and 
chromosome 18 (Badner and Gershon, 2002; Berrettini, 2003). These findings are 
also enhanced by association studies, CNVs studies and epidemiological studies 
(Christoforou et al., 2007).  
 
Many susceptibility genes are also associated both disorders. These include NPAS3, 
DISC1, ZNF804A, BRD1, PDE4B, SLC6A4 and G72/G30(DAOA) etc (Gomez et al., 





1.3 Adult neurogenesis and psychiatric illnesses 
1.3.1 The relation of neurogenesis and psychiatric disorders 
Adult neurogenesis, the process of generation of new neurons from adult neural stem 
cells, is sustained throughout adulthood in the mammalian brain (Gage, 2000). Adult 
neurogenesis might be involved in hippocampal aspects of neurodegenerative 
disorders or psychiatric disorders (Kempermann et al., 2008). Adult neurogenesis in 
SGZ can be activated by several physical and chronic antidepressant treatments 
(Warner-Schmidt and Duman, 2006). Cell proliferation is deregulated in several 
neurodegenerative diseases, such as Alzheimer’s disease (Verret et al., 2007), 
Parkinson’s disease (Nuber et al., 2008) and Huntington’s patients (Kohl et al., 2007). 
 
Although schizophrenia is not specifically a hippocampal disorder, failing adult 
neurogenesis may reflect the latest stages of a subtle misregulation of brain 
development and result in a particular set of hippocampal symptoms. Reif et al. (Reif 
et al., 2006) found a reduction in putative precursor cell proliferation in adult dentate 
gyrus by 63% in schizophrenia by investigating the brains of 15 patients with 








1.3.2 Adult Neurogenesis 
Two main locations of adult neurogenesis in the mammalian brain have been 
demonstrated under normal conditions: the subventricular zone (SVZ) of the lateral 
ventricles and the subgranular zone (SGZ) of the dentate gyrus in the hippocampus 
(Zhao, 2008). Adult hippocampal neurogenesis can be regulated by genetic 





Figure 1.1 Adult neurogenesis in dentate gyrus 
Neurogenesis involves cellular processes at several levels, including the proliferation 
of adult neural stem cells (NSCs) or progenitors, differentiation and fate 
determination of progenitor cells, and the survival, maturation, and integration of 




1.3.3 A number of candidate genes for susceptibility to psychiatric 
disorders are involved in neuronal development.  
Reduced expression of reelin in the cortex and the hippocampus in schizophrenia 
patients (Toro and Deakin, 2007) may result in disturbed adult neurogenesis (Forster 
et al., 2002; Heinrich et al., 2006) by a disturbance of neuronal migration and glial 
scaffolding (Won et al., 2006; Zhao et al., 2007). 
 
Disrupted in schizophrenia 1 (DISC1) is a schizophrenia susceptibility gene 
(Blackwood and Muir, 2004; Millar et al., 2000). It is expressed in the hippocampus 
and has diverse functions in neuronal migration, differentiation, neurite outgrowth 
and synaptic plasticity (Ross et al., 2006). A study on mutant mice for Disc1 shows 
that DISC1 and its co-operator, NDEL1, can regulate adult neurogenesis (Dranovsky 
and Hen, 2007; Duan et al., 2007). DISC1 is highly expressed in the embryonic 
ventricular/subventricular zones of the cortex, where neural progenitor cells reside, 
and plays important roles in the growth of the embryonic and postnatal brain (Mao et 
al., 2009). When DISC1 RNAi was introduced into neural progenitors in the 
developing neocortex of mouse brains, the proliferation of progenitor cells was 
significantly reduced and the premature neuronal differentiation and cell cycle exit 
were increased. The same group also found that knockdown of DISC1 resulted in a 
decrease in the proliferation of adult progenitor cells in the dentate gyrus.  
 
Neuronal basic helix-loop-helix (bHLH) PAS domain transcription factor 3 (NPAS3) 
is a member of basic bHLH PAS domain transcription factors, which is enriched in 
the inter-neurons in brain. NPAS3 is mutated in a family affected by schizophrenia 
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(Kamnasaran et al., 2003; Pickard et al., 2008; Pickard et al., 2005). Also Pickard et 
al. showed that interactions between variants across the NPAS3 gene might 
contribute to susceptibility to schizophrenia and bipolar disorders (Pickard et al., 
2008). A very significant reduction in hippocampal neurogenesis was found in Npas3 
knock-out mice (Pieper et al., 2005). These mice exhibited abnormal performance, 
such as reduced memory function, disturbed social behaviour and had reduced paired 
pulse inhibition (Erbel-Sieler et al., 2004).  
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1.4 NPAS3 is a strong candidate gene for psychiatric illness. 
Disruption of the NPAS3 (Neuronal basic helix-loop-helix (bHLH) PAS domain 
transcription factor 3) gene as a result of a chromosomal abnormality 
[t(9;14)(q34;q13)] carried by a mother and daughter diagnosed with schizophrenia 
and mild learning disability provided the first indication of a role for this gene in 
psychiatric illness (Kamnasaran et al., 2003; Pickard et al., 2005; Pickard et al., 
2006). This disruption lies within the intron 3 of NPAS3 gene. It results in the bHLH 
and PAS domains are being seperated from the transactivation domain, therefore, the 
functions of DNA binding and dimerisation may have been destroyed (Kamnasaran 
et al., 2003). Subsequent gene-specific and genome-wide case-control association 
studies have linked single nucleotide polymorphisms in the NPAS3 gene with 
increased risk of schizophrenia (Pickard et al., 2009) major depression disorder and 
bipolar disorder (Ferreira et al., 2008; Huang et al., 2010; Pickard et al., 2009). A 
recent report detailed the association of three common NPAS3 exonic variants with 
increased risk of schizophrenia (Macintyre et al., 2010). Additionally, genetic 
variation at the NPAS3 locus has been provisionally associated with risk of multiple 
sclerosis (Comabella et al., 2008), response to interferon beta treatment of multiple 
sclerosis (Byun et al., 2008), predisposition to addiction (Liu et al., 2006) and 
response to treatment with the antipsychotic drug, iloperidone (Lavedan et al., 2009). 
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1.4.1 The structure and function of NPAS3 
NPAS3 is expressed in 13 adult brain tissues including the hippocampus, thalamus, 
and cortex, especially in developing centre nervous system (Brunskill et al., 1999). 
NPAS3 encodes a member of the basic helix-loop-helix PAS domain transcription 
factor family that typically integrate environmental signals and heterodimeric 
binding partner availability to generate a transcriptional response (Brunskill et al., 
1999; Gilles-Gonzalez and Gonzalez, 2004; Zhou et al., 1997). In humans, the 




Figure 1.2. The structure of NPAS3. NPAS3 protein is composed a bHLH domain at 
the amino terminus, followed by two PAS domains. The carboxyl-terminal end 







1.4.2 The biology of the psychiatric disorder candidate gene-NPAS3 
NPAS3 is a brain-enriched transcription factor containing basic-helix-loop-helix 
motif and PAS domain. The bHLH-PAS superfamily has diverse functions in 
development or physiological events, including circadian rhythms, neurogenesis, 
toxin metabolism, response to hypoxia and tracheal development.  
 
The structures of bHLH-PAS proteins are highly conserved. The bHLH domain is 
located the amino terminus. Then it is followed by the PAS domain. The carboxyl-
terminal end contains transcriptional activation domains (Franks and Crews, 1994; 
Jain et al., 1994) or repression domains (Moffett et al., 1997). 
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1.4.3 The basis bHLH domain transcription factors 
A basic helix-loop-helix domain is composed of 2 α-helices connected by a loop. 
Generally, the smaller helix can bind to another protein by folding and packing 
against another helix. The larger helix, which contains the DNA binding region, 
typically binds to a consensus DNA sequence (E-box, CANNTG) (Chaudhary and 




Figure 1.3. basic helix-loop-helix DNA binding domain (Massari and Murre, 2000). 
Two alpha-helices (blue) are connected by a short loop (red) 
 
The bHLH-PAS proteins share a number of similarities with other members of 
bHLH proteins (Littlewood and Evan, 1995). For example, bHLH proteins are 
important in regulation of cell lineage (Isaac and Andrew, 1996; Thomas et al., 1988) 




1.4.4 The functions of bHLH superfamily  
 There are many transcription factors containing a bHLH domain, such as: 
• AhR 
• Beta2/ NeuroD1 
• BMAL-1-CLOCK 




• NPAS3, NPAS1, NPAS2, MOP5 
• Scl 
• Neurogenins 
• BHLHB2, BHLHB3, BHLHB4, BHLHB5, BHLHB8 
 
Usually, transcription factors with this domain exert their function with another 
subunit through heterodimerization, including BMAL1-NPAS3 complex and 
BMAL1-CLOCK complex. The activity of the heterodimeric complex is often 
determined by the dimerization of the subunits. The level or availability of one 
subunit is restricted, whereas the other subunit is broadly expressed. The 
combinatorial properties of bHLH members explain the possibility that bHLH 
proteins play important roles in a variety of complex biological events. For example, 
BMAL1-CLOCK is a very important complex in regulating circadian rhythm, and c-
Myc and HIF-1 are linked to cancer through their effect on cell growth and 
metabolism. 
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1.4.5 The structure and function PAS domain 
The PAS domain is a signal sensor in many signalling proteins (Dunham et al., 2003; 
Hefti et al., 2004; Ponting and Aravind, 1997). This domain was named after three 
proteins which contain it: 
• Per- period circadian protein 
• Arnt- Ary hydrococarbon receptor nuclear translocator protein 
• Sim- single-minded protein 
 
The PAS domain includes two degenerate direct repeats (around 50 amino acids) 
(Crews, 1998). The PAS domain in bHLH-PAS proteins is about 260-310 amino 
acids. It includes two conserved regions (PAS-A and PAS-B) linked by a spacer 
(Crews et al., 1988). Many PAS-domain proteins exert their function by dimerization 
between PAS proteins (Huang et al., 1993), interaction with non-PAS proteins 
(Dolwick et al., 1993; Gekakis et al., 1995) and binding small moleculars, such as the 
heme ligand (Gilles-Gonzalez and Gonzalez, 2004)  
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1.4.6 Npas3 deficient animal model  
A mouse Npas3 knockout displays a range of behavioural phenotypes consistent with 
it being a representative model of human psychiatric disorders, including increased 
locomotor activity, stereotypic darting behaviour at weaning, subtle gait defects, 
impairment of prepulse inhibition of acoustic startle, deficit in recognition memory 
and altered anxiety-related responses. (Brunskill et al., 2005; Erbel-Sieler et al., 
2004). It also displays an additional deficit in adult hippocampal neurogenesis 
(Pieper et al., 2005). 
 
 Both Npas1 and Npas3 knockout mouse strains also show developmental lung 
phenotypes impacting neonatal survival rates but how this pathology relates to 
central nervous system observations is currently unknown (Levesque et al., 2007; 









1.5 Summary and hypothesis 
Schizophrenia and bipolar disorder are common, lifelong psychiatric illnesses 
affecting mood, perception and cognition. Family and epidemiological studies have 
indicated that these conditions are strongly influenced by genetic facors. Therefore, 
the functional study of candidate genes will aid the description of underlying 
pathologies and guide the search for new therapeutic approaches. NPAS3 is a strong 
risk factor for schizophrenia and bipolar disorder. Npas3 knockout mice also exhibit 
behavioural and adult neurogenesis deficits consistent with human illness. A set of 
questions about NPAS3 were addressed in my PhD project. 
1.5.1 What is the expression pattern of NPAS3 in adult hippocampus? 
It was reported that Npas3 (-/-) mice are associated with hippocampal neurogenesis 
deficit. This result suggested NPAS3 might directly regulate the developmental 
pathway associated with new neuron production. Investigation of the expression 
pattern of NPAS3 in adult mice hippocampus will be necessary to reveal its role 
during adult neurogenesis.  
1.5.2 What is the regulatory profile of NPAS3? 
As a transcription factor, the investigation of NPAS3’s transcriptional regulatory 
profile is particularly significant because observed expression changes are likely to 
represent direct activity rather than secondary or homeostatic reactions. Full-length 
(FLNPAS3) and artificially truncated (∆NPAS3) forms of NPAS3 were over-
expressed in the human embryonic kidney cell line, HEK293, followed by 
microarray analysis to identify target genes. 
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1.5.3 How does the regulation profile of NPAS3 compare with SOX 
transcription factors? 
Many SOX members are known neurodevelopmental regulators and SOXD/E 
members are particularly important during the process of converting neural 
progenitors into immature neurons. Sox11 was found strictly colocalized with Dcx –
expressing precursors and immature neurons, but not with Sox2-expressiong non-
committed precursors and immature cells (Haslinger et al., 2009). Npas3 was found 
only colocalized with Dcx in adult mouse hippocampus in our study, furthermore. 
There are also association evidence supporting roles for SOX5 in metabolic side-
effects of antipsychotic treatment and SOX10 in increased risk of psychiatric illness 
(Maeno et al., 2007). We were really interested to investigate whether SOX members 
and NPAS3, as transcription factors might have some interaction. The target genes of 
NPAS3 were compared with the SOX family of transcription factors (Azim et al., 
2009; Bergsland et al., 2006; Cheung and Briscoe, 2003; Hamada-Kanazawa et al., 
2004; Haslinger et al., 2009; Kim et al., 2003; Kwan et al., 2008; Lefebvre, 2009; 
Prior and Walter, 1996).  
1.5.4 How does circadian rhythm affect NPAS3? 
NPAS2 is one of the components of the circadian clock oscillator. The other 
components include the CRY proteins, CLOCK, BMAL1, BMAL2, CSNK1D, 
CSNK1E, TIMELESS and the PER proteins. BMAL1 is able to heterodimerise with 
NPAS3 to regulate transcription of genes. As NPAS3 closely interacts with circadian 
regulators, we wished to know whether NPAS3 activity was sensitive to circadian 
context or if, indeed, it could directly regulate it. An additional microarray study was 
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carried out in which cells over-expressing NPAS3 were stimulated to commence 
synchronous circadian cycling.  
 
In order to answer these questions, several projects were carried out. The detail will 




























2 Materials and Methods 
2.1 Materials 
2.1.1 Suppliers  
Sigma-Aldrich Limited, Poole, Dorset, UK 
Sigma-Genosys, Ltd, London Road, Pampisford, Cambridge, UK 
Invitrogen Ltd, Paisley, UK 
Promega, Ltd, Southhampton, UK 
Qiagen, Ltd, West Sussex, UK 
GRI, Essex, UK 
New England Biolab (UK) Ltd, Hitchin, Hertfordshire, UK 
Stratagene, Amsterdam, Netherlands 
Cambrex BioScience Rockland Inc, Rckland, USA 
Roche Diagnostics Ltd, Lewes, East Sussex, UK 
Hybaid, Teddington, UK 
ABgene, Surrey, UK 
Anachem Ltd, Bedfordshire, UK 
Sarstedt, Leicester, UK 
Corning Ltd, Buckinghamshire, UK 
Cheshire Scientific Ltd, South Wirral, UK 
Fisher Scientific Ltd, Leicestershire, UK 
Sciquip Ltd, Shropshire, UK 
Applied Biosystems, CA, USA 
USB Corporation, Cleveland Ohio, USA 
Amersham Pharmacia Biotech UK Ltd, Buckinghamshire, UK 
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2.1.1.1 General Plastic ware 
Micro tubes 0.5ml, 1.5ml, and 2ml Sarstedt 
Tissue culture plasticware Corning 
0.2ml Flat and Domed cap tub Abgene 
Thermo-Fast 96, skirted Plate                                                     Abgene 
Flat cap strip                                            Abgene 
Culture Loops Cheshire 
Microbiological spreader Cheshire 
 
       
2.1.1.2 Apparatus 
Horizontal electrophoresis tank Hybaid 
MJ Research Thermocycler GRI 
Balance Fisherbrand PS-200 Fisher 
Microcentrifuge eppendorf 5415D Fisher 
IKA Minishaker MS 2 Fisher 
Syngene Bio Imaging system Fisher 
Sigma Laboratory centrifuge 4-15, 4K15 Fisher 











2.1.1.4 Media and Media Components 
Alpha MEM   Invitrogen 

















2.1.1.5 Molecular Biology products 
Dual Luciferase Reagent                                                               Promega 
pGL-3 Luciferase vector (control& basic) Promega 
pRL-TK vector                                                                              Promega 
Taq PCR core kit   Qiagen 
PRISM BigDye Terminator cycle sequencing kit Applied Biosystems 
NuPAGE® Novex® Tris-Acetate gels Invitrogen 
SYBR GreenTM qPCR SuperMix Universal         Invitrogen 
ECLTM Western Blotting Detection Reagents AmershamTM 
QIAquick gel extraction kit                            Qiagen 
Qiagen PCR purification kit                           Qiagen 
Qiagen plasmid mini kit                                 Qiagen 
Subcloning Efficiency TM DH5α competent cells Invitrogen 
T4 DNA Ligase and buffer Roche 
Shrimp Alkaline Phosphatase USB Corporation 
PCR primers and oligos Sigma-Genenosys 
Orange G loading dye                                   Sigma-Aldrich 
Ethidium Bromide                                             Sigma-Aldrich 
Restriction endonucleases and buffer               New England Biolabs 
T4 DNA polymerase, buffer and EDTA NEB 
Agarose Powder                                                                           Bio-Rad 
0.1M DTT Invitrogen 
DNase I Invitrogen 
dNTPs Invitrogen 
Bovine serum albumin                                     New England Biolabs 
1 kb DNA Ladder                                         Promega 





2.1.2 Solutions, buffers and gel loading dyes 
Ampicillin stock solution (10mg/ml) 
Ampicillin sodium salt                             5g 
Qs (Quantity sufficient) 50ml dsH2O 
 Filter-sterilized and store at -20° 
 
Blocking buffer (western blot) 
Marvel Skimmed milk powder              2.5g 
PBS                                                     50ml 
TWEEN                                               100µl 
 
Blocking buffer (immunofluorescence) 
donkey serum                                     100µl 
PBS/1% TWEEN 20                            10ml 
 
1M DDT 
Dithiothreitol                                        0.7g 
Qs 5ml dsH2O 
 
EDTA solution 0.5M pH8.0 
Disodium ethylenediaminetetra acetate       1.861g 





30ml ethanol (99.7-100% v/v) to every 100ml dsH2O 
 
70% Ethanol 
70ml ethanol (99.7-100% v/v) to every 100ml dsH2O 
 
90% Ethanol 
90ml ethanol (99.7-100% v/v) to every 100ml dsH2O  
 
50% Formamide Solution 
Formamide (99%)                                     500ml 
2×SSC                                                      100ml 
dsH2O                                                      400ml 
 
Luria-Bertani broth (LB) 
1% (w/v) Bacto-Tryptone (Difco) 
0.5% (w/v) Bacto-Yeast extracts (Difco) 
0.1% (w/v) NaCl 
pH 7.0 autoclave 
 
LB-agar 




Orange G loading buffer 
Glycerol                                                       30ml 
dsH2O                                                          70ml 
Orange G                                                      1g 
 
1×PBS  
KH2PO4                                                                                       1.157g 
Na2HPO4                                                                                    6.971g 
NaCl                                                               43.83g 
Qs 500ml dsH2O 
 
PBS/1%TX100 
PBS                                                                 495ml 
TX100                                                               5ml 
 
Primer mix 
Glycerol                                                                                 6ml 
TE                                                                                          7ml 
DMSO                                                                                   1ml 
 
Running Buffer (for Tris-acetate gels) 
20x Nupage Tris-acetate SDS running buffer                       25ml 




Tris (hydroxymethyl)-methylamine (pH7.5)                         0.61g 
NaCl (150mM)                                                                       0.9g 
dsH2O                                                                                    80ml 
1% Triton X-100                                                                    1ml 
Sodium deoxycholate (10% solution)                                   2.5ml 
Sodium deoxycholate (20% solution)                                  250µl 
1mM EGTA (100mM solution)                                               1ml 
Add 100µl protease inhibitors to 5ml RIPA lysis buffer before use 
 
20x TBE 
Tris                                                                                        242.0g 
20mM EDTA                                                                          14.88g 
Boric acid                                                                               123.4g 
Qs 1L dsH2O autoclave 
 
TE pH 8.0 
10mM Tris Cl  pH 7.4 
1mM EDTA     pH 8.0 
 
Transfer Buffer  
20x NuPage Transfer buffer                                                     25ml 
Methanol                                                                                 100ml 
dsH20                                                                                      375ml 
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0.05 Tris-HCL pH 6.7 
Trizma hydrochloride                                                                  7.88g 




Wash Buffer (western blot) 
10x PBS                                                                                       100ml 
dsH2O                                                                                          900ml 
Tween                                                                                            2ml 
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2.1.3 Primers  
Genomic sequence information for genes was obtained from NCBI. Ologonucleotide 
primers were designed using PRIMER3 [http://workbench.sdsc.edu] (Rozen and 
Skaletsky, 2000). Specificity of all primers was checked by Blast and BLAT analysis 
http://www.ncbi.nlm.nih.gov/Blast.cgi, http://genome.ucsc.edu/cgi-bin/hgBlat. 
Primer sequences are listed in (table 2.1 and 2.2) PCR Primers were re-suspended at 
a concentration of 100µg/µl in primer mix and stored at -20° C. 
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Table 2.1 PCR primers used in validation of SOX11 microarray and timecourse 
QPCR assay. 
 
Primer Name Sequence 
SOX11 QPCR forward  GACTTCCCCGACTACTGCAC 
SOX11 QPCR reverse  TAGGTG AACACCAGGTCGGA 
SEMA3B QPCR forward GACCTCATGGGACGAGACTT 
SEMA3B QPCR reverse ACCTTGACAAACTTGGGCTC 
NEDD9 QPCR forward ACACCATCTACCAAGTGCCA 
NEDD9 QPCR reverse ATGCTTCTCTGCACTGATGG 
GSTA2 QPCR forward AACCTGAGGAACAAGATGCC 
GSTA2 QPCR reverse AAGGTAGTCTTGTCCGTGGC 
GPC2 QPCR forward GCTCCTTTCTGGTTCACACA 
GPC2 QPCR reverse CGTAGGAGTGGGAGAAGAGC 
BAG1 QPCR forward ACAGCAATGAGAAGCACGAC 
BAG1 QPCR reverse CTGTGGAACCCCTATGACCT 
HIST1H2BE QPCR forward ACACCGGCATCTCCTCTAAA 
HIST1H2BE QPCR reverse GTCGAGCGCTTGTTGTAATG 
HIST1H2AE QPCR forward CTAAAACGCGTTCTTCCAGG 
HIST1H2AE QPCR reverse TCGTTCGGACTAGTTGCCTT 
SCG2 QPCR forward GAAGCGAGTTCCTGGTCAAG 
SCG2 QPCR reverse TCCTGAGAGCTGCCTTGATT 
CD24 QPCR forward TAGCTGGGATTACAGGCACC 
CD24 QPCR reverse GTCAGGAGTTCGAAACCAGC 
FILIP1 QPCR forward TCAGTTTAAACGGTCCCCTG 
FILIP1 QPCR reverse TTCGGCTGTCACGTTTACTG 
TUBB3 QPCR forward AGGCCTGAAGAGATGTCCAA 
TUBB3 QPCR reverse AACGAGGCCTCTTCTCACAA 
CYP39A1QPCR forward CGAAGGAGAGCTGCAAAAGT 
CYP39A1 QPCR reverse CTTGCTTCTTTTCTGTGGGC 
NDP QPCR forward TGTCGTTCAGCACTGTCGCG 
NDP QPCR reverse CTTCAGCTTGGAAGTCTGGG 
GAPDH QPCR forward ACAGTCAGCCCGCATCTTCTT 
GAPDH QPCR reverse ACGACCAAATCCGTTGACTC 
SOX11 attb forward primer GGGGACAAGTTTGTACAAAAAAGCAGGCTGATCACGGTT
CAACACACGGAAC 













Table 2.2 PCR primers used in validation QPCR for NPAS3 microarray, circadian 
gene detection and VGF promoter assay. 
 
 
Primer name Sequence 
SOX11 QPCR FORWARD GACTTCCCCCACTACTGCAC 
SOX11 QPCR REVERSE TAGGTGAACACACCAGGTCGGA 
SOX3 QPCR FORWARD ATGAACGGCTGGACTAATGG 
SOX3 QPCR REVERSE GGAGCTCTGCTGGTTGTAGG 
SOX4 QPCR FORWARD GTGAGCGAGATGATCTCGGG 
SOX4 QPCR REVERSE CAGGTTGGAGATGCTGGACTC 
HK2 QPCR FORWARD ATACGGTTGCTTCACCTTGG 
HK2 QPCR REVERSE TCAGGCTCACATCTCAGTG 
ENO2 QPCR FORWARD TGTCTCATCCTCCTGGAACC 
ENO2 QPCR REVERSE TCAATCAGGGAAGTTCTGGG 
NPAS3 QPCR FORWARD TCGGCATTTTCGTTTAGACC 
NPAS3 QPCR REVERSE AAGAAAGAGGGGGTGGAATG 
VGF QPCR FORWARD GAGCATAAAGAGCCGGT 
VGF QPCR REVERSE GAAAAGCTCTCCCTCGTCCT 
18s RNA QPCR FORWARD GGGAGGTAGTGACGAAAAATAACAAT 
18s RNA QPCR REVERSE TTGCCCTCCAATGGATCCT 
VGF PROMOTER FORWARD GGCCCTCGAGGGAGGTTAGAAGGAGGGTCAGT 
VGF PROMOTER REVERSE GGCCCCATGGCTACCGGCTCTTTATGCTCAGA 
M13 FORWAR SEQUENCING 
PRIMER 
GTAAAACGACGGCCAG 
M13 REVERSE SEQUENCING 
PRIMER 
CAGGAAACAGCTATGAC 
VGF PROMOTER SEQUENCING 
PRIMER FORWARD 787 
GGTGGAGAGAGCTGGAGTTG 
VGF PROMOTER SEQUENCING 
PRIMER FORWARD 1325 
ACGCTGGGACTACCCTTTTT 
VGF PROMOTER SEQUENCING 
PRIMER REVERSE 806 
CAACTCCAGCTCTCTCTCCACC 
VGF PROMOTER SEQUENCING 
PRIMER REVERSE 1344 
AAAAAGGGTAGTCCCAGCGT 
VGF PROMOTER SEQUENCING 
PRIMER REVERSE 1945 
GAGAGGTGGAGAGGAGGGTC 
PER1 FORWARD AGGTACCTGGAGAGCTGCAA 
PER1 REVERSE TTCTTGGTCCCCACAGAGAC 
PER2 FORWARD AAATGGATCCCCCTTGAATC 
PER2 REVERSE AGCACCACCTGGTGTACCTC 
PER3 FORWARD TCCTGGCGTCTTCTCACTTT 
PER3 REVERSE TCATACCGTGCAGCTCTTTG 
 
2.1.4 Cell lines 
In-house cell lines HEK293 (human embryonic kidney), SH-SY5Y (human 
neuroblastoma derived) and U373 were cultured using standard laboratory practice. 
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2.2 General methods 
Molecular biology techniques were developed from (Sambrook et al., 1989), unless 
otherwise stated. 
 
2.2.1 Miniprep preparation of Bacterial DNA 
A single bacterial colony was used to inoculate 5ml of LB-Broth with the appropriate 
antibiotic added. The cultures was grown overnight at 37°C in a shaker incubator. 
2ml of bacterial culture was centrifuged for 5 minutes at 3000rpm. DNA was isolated 
from the pellets using the Qiagen plasmid mini kit. In brief, the pellet was 
resuspended in 0.3ml of P1 solution before adding 0.3ml P2 and incubated for 5 
minutes at room temperature. Next, 0.3ml of P3 was added and the lysate incubated 
for 10 minutes on ice before centrifugation at 13000rpm for 10 minutes. 
 
The supernatant was transferred to a new micro-tube, 0.8ml of isopropanol added 
and left on ice for 15 minutes followed by centrifugation at 13000rpm for 15 
minutes. The supernatant was subsequently removed and 0.5ml of 70% alcohol 
added to wash the pellets before centrifugation at 13000rpm for 5 minutes. The 
supernatant was again removed and the pellets air dried at room temperature. Once 
the DNA pellets had become translucent they were re-suspended in 40µl TE (pH 8.0) 
and left to sit for one hour at room temperature before storage at -20°C. The quality 




2.2.2.1 Polymerase Chain Reaction 
Standard PCR amplification reactions were performed using Invitrogen reagents. 
However, when amplifying long sequences, or if the sequence had a high GC 
content, the Expand long-range PCR kit (Roche) was used. Using Invitrogen 
reagents, PCR was performed with a final volume of 25ųl comprised of:  
25-50ng                        template DNA 
2.5ųl of 2mM                dNTPs 
5µmol                           primer 
2.5µl                            10xPCR Invitrogen amplification Buffer;  
7µl                                dsH2O; 
0.25U                            Taq DNA polymerase (Invitrogen) 
10µl                               1x enhancer solution.  
 
The PCR reactions were carried out on a Gene Engine thermocycler (MJ Research 









2.2.2.2 Agarose gel electrophoresis 
DNA/RNA integrity and PCR reaction efficacy were determined by Agarose gel 
electrophoresis. In general, agarose gels of 2% and 0.8% were used for resolution of 
small (~ 0.2kb-1kb) and large (>1kb) fragments respectively. Agarose gels were 
prepared by heating agarose in 1xTBE buffer. After dissolution of the agarose, 
SYBR SafeTM was added to the gel at a final concentration of 1µl/100ml. Sample and 
1kb DNA ladder were loaded using orange G loading buffer. Electrophoresis was 
performed using Hybaid Electro-4 gel tanks. The gel was submerged in 1xTBE 
buffer and a current of 80-100V was passed through the buffer to allow migration of 
the DNA through the gel. Fragments were visualized using by UV transillumination 
(Thistle Scientific) and images captured using a digital imager, Uvidoc (Uvitec).  
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2.2.3 Cloning PCR products 
The cloning of PCR products was used to create a SOX11 expression plasmid 
contruction. Following purification, PCR products were cloned using the Qiagen 
PCR cloning kit (Qiagen). In brief, 1µl of pDrive cloning vector and 5µl ligation 
master mix was added to 4µl of purified PCR DNA gently mixed and incubated at 
16°C overnight.  
 
Transformation of PCR DNA was executed using a heat shock method as follows. 
2µl of ligation reaction mix was added to 25µl of E-coli competent cells, incubated 
for 30 minutes, heat shocked at 42°C for 30 seconds and left on ice for one minute. 
Subsequently the ligation reaction/competent cell mix was added to 250µl of L-broth 
growth media already warmed to 37°C and left on a shaker to incubate for one hour.  
 
The L-broth medium mix was plated on agar plates treated with chromogenic 
substrates IPTG and X-Gal to determine the efficacy of transformation - a technique 
termed ‘blue/white screening’. Agar plates were made by heating agar to 50°C, 
adding appropriate antibiotics (1µl/ml of ampicillin [100mg/ml stock]), poured into 
Petri dishes and briefly dried in an oven.  40µl of IPTG (100mM) and X/Gal (40 
mg/ml) was spread over each plate before the L-broth medium transformation mix 
was plated and left to incubate in an inverted position at 37°C overnight. As 
approximately half of the cloned PCR product colonies should contain the mutant 
allele, DNA from 10 colonies of each variant was purified. The white colonies which 
indicated no production of the enzyme β-galactosidase and hence successful 
incorporation of plasmid DNA were subsequently cultured in L-broth, pelleted and 
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DNA isolated using the GenEluteTM Plasmid Purification kit (Sigma-Aldrich) 
according to manufacturer’s instructions.   
 
The cloned PCR product DNA was directly sequenced using the Qiagen PCR 
cloning kit T7 promoter primer. The sequencing reaction was performed using the 
BigDye® Terminator Ready Reaction Mix v3.1 with a final volume of 10ul 
comprising of 1µl BDv3.1, 1µl primer 3.2µM, 2µl cloned DNA and 6µl dsH2O. 
Primer details are presented in table2.2. Sequencing reactions were performed on a 
MJ Research Peltier Thermal Cycler using following cycling conditions: 96°C -1min, 
96°C -10s, 50°C -5s 60°C -4 min times 25 cycles; 4°C -10min. Following the 
sequencing reaction, products were precipitated in an Ethanol/EDTA solution and 
run on an Applied Biosystems 3730 DNA analyser.  
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2.2.4 Reverse-transcriptase PCR  
2.2.4.1 RNA preparation 
RNA was extracted using RNeasy Mini Kit (Qiagen) as per manufacturer’s 
instructions. In brief, cell samples were thawed before adding 600µl RLT buffer 
(containing guanidine-thiocyanate to inactivate RNases hence ensuring purification 
of intact RNA) and homogenized in a QIA shredder spin column (Qiagen) spun for 2 
minutes at 13000 rpm. An equal amount of 70% EtOH was added to the lysate, 
mixed well and applied to an RNeasy mini spin column spun at 10000 rpm for 15 
seconds. The sample was then washed in 350µl RW1 buffer, spun at 10000 rpm for 
15 seconds before 80µl of DNase1 incubation mix was dispensed directly onto the 
spin column membrane and left at room temperature for 15 minutes. The column was 
then again washed in RW1 buffer and 500µl RPE buffer added, spun for two minutes 
at 10000 rpm. RNA was then eluted in 30µl RNase-free water and stored at -70°C.  
 
5 µl of the solution was lorded onto a standard (non-denaturing) 1.5 % agarose gel 
with 0.5xTBE buffer to check the amount and integrity of the RNA. Ethidium 
bromide (EtBr) is added to the gel to avoid the additional (potentially RNAse-prone) 
step of gel staining. Load a known amount of DNA in a neighboring lane to use as 
standard for determining the RNA concentration. Intact RNA should exhibit sharp 
band(s) of ribosomal RNA. 
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2.2.4.2 cDNA synthesis 
RNA was reverse transcribed to cDNA with First Strand cDNA Kit (Roche) using 
oligo-p(dT)15 primer. This technique produces single stranded RNA using AMV 
reverse transcriptase. The synthesis reactions were performed with a final volume of 
20µl master mix comprised of:  
2µl                       10 x reaction buffer 
4µl                       25mM mgCl2 
2µl                       10mM dNTPs 
2µl                        oligo-p(dT)15 primer 
1µl                        RNase inhibitor 
0.8µl                     AMV reverse transcriptase 
8.2µl                     dsH2O 
 
The reactions were cycled on a thermal cycler (Pelter PTC-225) as follows: 25°C -
10min, 42°C -10min, 99°C -5min, 4°C -5 min. cDNA was stored at -20°C . 
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2.3 Immunofluorescence 
2.3.1 Fixation of Brain Tissue 
Adult mouse brains were submerged in a solution of 4% paraformaldehyde in 1× 
PBS for 8-16 hours at 4°C on a rocking platform. The brains were then washed with 
1×PBS and placed in a 30% sucrose:PBS solution for cryoprotection and left 
overnight at 4°C with agitation until the brains sank. Brains were placed in OCT 
(Lamb), positioned in the horizontal, coronal or sagittal plane, frozen on dry ice and 
then stored at -80°C. 
 
2.3.2 Sectioning of frozen brain tissue 
Brains for cryostat sectioning were removed from storage at -80°C and equilibriated 
at -20°C to -26°C for one hour in the cryostat. 10µm-thick sections were cut on the 
cryostat and collected onto Superfrost Plus (BDH) slides. All sections were air-dried 
prior to storage at -80°C with a dessicant until use. Prior to immunofluorescence, 
slides were taken straight into ice cold actone for 7 minutes fixation.  
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2.3.3 Fluorescent endpoint 
The sections were fixed in ice cold acetone for 5 minutes and air dried for 30 minutes, 
then washed in 0.1% Triton in phosphate-buffered saline (pH 7.4). Unless stated 
otherwise, all steps were carried out at room temperature. The sections were first 
incubated for 1 h in 2% donkey serum to reduce background staining. The sections 
were then placed in single/double antibody solutions in 2% donkey serum, and 
incubated in these solutions for overnight at 4 °C. The following antibody solutions 
and dilutions were used: 1/500 Sox11 rabbit anti mouse, 1/400 Npas3 goat anti 
mouse, 1/400 Dcx rabbit anti mouse, 1/400 Gfap rabbit anti mouse, 1/500 Nestin 
rabbit anti mouse, 1/400 Gpc2 goat anti mouse (Santa Cruz Biotechnology). 
Following several washes over the period of 1 h, the sections were incubated for 1h 
in appropriate combinations of 1:400 donkey anti-goat or -rabbit IgG secondary 
antibodiest, conjugated to Alexa Fluor 594 for red fluorescence, or to Alexa Fluor 
488 or FITC for green fluorescence (the Alexa Fluor secondary antibodies were 
purchased from Invitrogen Life Technologies, Paisley, UK). Finally, after several 
washes, the sections were mounted on slides with Prolong antifade reagent with 4’6-
diamidino-2-phenylindole (DAPI) (Invitrogen) and the coverslips were then sealed in 
nail varnish. 
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2.4 Luciferase Reporter Assay 
2.4.1 An overview of the technique 
Luciferase reporter assay systems are currently one of the best non-toxic, rapid and 
sensitive methods to measure gene expression. The assay is based on the detection of 
luciferase activity driven by a promoter/enhancer cloned upstream of the luciferase 
gene. Luciferase activity correlates with the transcription regulated by the cloned 
DNA regulatory elements as well as response to extracellular and intracellular 
signals. In the quantification of gene expression using firefly luciferase (pGL3-
control/Basic vector), a second Rennila luciferase vector (pRL-TK vector) is 
commonly used as internal control co-transfected into mammalian cells. The Dual-
Luciferase ® Reporter  (DLR) Assay system integrates the assays of both Firefly and 
Renilla luciferase from the same sample by the sequential measurement of their 
cognate substrate luciferins respectively. 
 
2.4.2 Construction of VGF promoter-Luciferase Reporter Vectors 
2.4.2.1 Generating 5’ VGF promoter fragment by Long-PCR 
To create the reporter vector, PCR was carried out to amplify 2029kb 5’ human VGF 
sequence containing promoter, exon1, intron1 and part of exon2 with the following 
primers. HindIII forward: GGCCCTCGAGGGAGGTTAGAAGGAGGGTCAGT and XhoI 
reverse: GGCCCCATGGCTACCGGCTCTTTATGCTCAGA. Using the Expand long-range 
PCR kit (Roche), a total volume of 16ųl comprised; 25ng template DNA; 25mM of 
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each dNTP; 5µmol primer; 1.7µl expand long-range Buffers 2 &3; 13.3µl dsH2O 
and, 0.25U Invitrogen Taq DNA polymerase.  
The cycling conditions for this PCR reaction consisted of an initial incubation for 5 
mins at 94°C, followed by 9 cycles of 15 sec at 94°C, 1 min at 56°C and 4 min at 
68°C followed by 20 cycles of 94°C for 1 min, 56 for 1 min and 68°C for 4 min with 
10 sec increase per cycle. The PCR product was then digested by HindIII  and XhoI 
restriction enzymes and purified with Qiagen PCR purification Kit. 1 µl of the 
purified digested product was then loaded on 1% agarose gel along with 1Kb DNA 
ladder (NEB, UK) for an approximate quantification. 
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2.4.2.2 Generating VGF-luciferase Reporter Vector 
The pGL3-basic vector was kindly provided by Professor Rob van t’ Hoff. 3µg of the 
modified pGL-3 basic vector was digested by 30 units of HindIII and 30 units of 
XhoI restriction enzymes (NEB, UK) with 3µl 10×NEbufferB, 1.5µl 20×BSA and 
deionized water up to 30µl at 37°C for 2 hours. The digestion mix was purified with 
Qiagen PCR purification kit and then dephosphorylated with shrimp Alkaline 
Phosphatase (SAP, USB Corporation, UK) 
 
The SAP treatment was set up as following: 
3µl       Shrimp Alkaline Phosphatase (1U/µl)  
4µl       10 × Shrimp Alkaline Phosphatase reaction buffer 
30µl      purified digested DNA (<3µg) 
3µl       ddH2O 
 
The reaction was incubated at 37°C for 30 minutes and inactive at 65°C for 15 
minutes. The DNA from the SAP treatment was used directly as vector in the ligation 
reaction. The following formula was used to calculate the amount of insert and 
vector in the ligation reaction: 
[{ Amount of vector(ng)* length of insert (kb)}/length of vector(kb)]* A 
The molecular ratio of vector DNA to insert (‘A’ in the formula) is 1:3 for sticky 
ends when insert DNA and vector were approximately similar in length, otherwise 
ratio 1:1 or 1:2 was used. 
In this study, the molar ratio of insert to vector was 1:2. Therefore, the reaction mix 
contained 100ng of 4.8kb vector, 300ng 2.0kb insert, 1µl to T4 DNA ligase (1U/µl, 
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Roche, UK), 1µl of 10× ligation buffer and water up to 10 µl. The ligation mix was 
incubated at 16°C for 16 hours. 2 µl of the ligation mix was added to 50 µl of 
Subcloning Efficiency TM DH5α competent cells (Invitrogen, UK). The 
transformation and the incubation of the agar plate were carried out as described 
above. Five clones were picked out to incubate in 5 mls LB broth at 37 °C overnight 
with constant shaking at 225rpm. After the same procedures for miniprep and 
quantification, the correct integration of promoter insert into plasmid DNA was 
confirmed by HindIII and XhoI double digestion. The plasmid with correct digestion 
products was sequenced with primers listed in table 2.2. The sequence reactions with 
these primers covered all the 4kb insertion and 100bp of luciferase gene. 
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2.4.3 Quantification of reporter vectors by Fluorimetry 
 DNA concentration was measured using Quant-iTTM PicoGreen® dsDNA Assay 
Kit on a Bio-TEK Synergy HT multiwell plate reader. First a standard curve was 
constructed using double-stranded λ DNA at known concentrations. DNA samples 
were analyzed in duplicate and their average concentrations calculated from the 
standard curve regression equation. Pico green assays (100µl at 20µg/ml) was added 
to each well of a black 96 well microtitre plate with clear bottom along 100µl of 
either DNA samples or DNA standards of known concentrations. The plate was read 
after incubation at room temperature for 5 minutes. The fluorimeter measured the 
relative absorption ratio of each sample at 360nm excitation and 460 emission 
wavelength to create a concentration value. Each well was read twice and a mean 
value caculated. 
 
2.4.4 Transfection of the vectors into human cells. 
All transient transfection experiments were carried out using the human HEK293 and 
SHSY-5Y cell lines. Cells were cultured in 75 cm2 tissue culture flasks in alpha 
MEM medium (Invitrogen) supplemented with 10% fetal calf serum (FCS, 
Invitrogen), 50 IU/ml penicillin (Invitrogen) and 2 mM glutamine (Invitrogen). 
Medium was renewed every 3 days. Cells were incubated at 37°C in a humidified 
atmosphere of 5%CO2. 
Twenty-four hours prior to the transfection, cells were cultured in 24-well plates with 
the density of 4×104. On the day of transfection, cells with less than 50% confluence 
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were transfected using lipofectamine 2000 (invitrogen) with these sets of plasmids 
respectively: 
 
 1) VGF luciferase reporter vector, pRL-TK and pDEST40-FLNPAS3  
2) VGF luciferase reporter vector, pRL-TK and pDEST40- ∆NPAS3  
3) VGF luciferase reporter vector, pRL-TK and pDEST40-SOX5 
4) VGF luciferase reporter vector, pRL-TK and pDEST40-SOX6 
5) VGF luciferase reporter vector, pRL-TK and pDEST40-SOX5+SOX6 
6) VGF luciferase reporter vector, pRL-TK and pDEST40-SOX9 
7) VGF luciferase reporter vector, pRL-TK and pDEST40-SOX10 
8) VGF luciferase reporter vector, pRL-TK and pDEST40-SOX9+10 




















2.4.5 Measurement of the luciferase activity 
Twenty–four hours after transfection, cells were checked to be no more than 95% 
confluent. The growth medium was removed from the cultured cells and 2ml of 
phosphate buffered saline (PBS) was added to wash the surface of 24-well plate. The 
plate was swirled briefly to remove detached cells and residual growth medium. The 
rinse solution was completely removed before applying passive lysis buffer (PLB, 
Promega, UK). 80µl of 1×PLB was added into each well in the 24-well plate to 
completely cover the cell monolayer. The plate was wrapped with foil paper and 
stored at -80°C for at least 24 hours prior to performing the DLRTM Assay. 
Luciferase assay regeant II (LAR II, Promega, UK) was prepared by resuspending 
the provided lyophilized Luciferase Assay Substrate in the 10ml of the supplied 
Luciferase Assay buffer II. Once the substrate and buffer had been mixed, LAR II 
was aliquoted and stored at -80°C. Frozen aliquot (80µl/sample, 2.5ml) of LAR II 
were thawed at room temperature before use. Stop & Glo® reagent was prepared by 
adding 1 volume of 50× Stop & Glo® substrate (Promega, UK) to 50 volumes of 
Stop & Glo® buffer. For each measurement (80µl/sample) 50 µl of 50× Stop & Glo® 
substrate was added to 2450 µl of Stop & Glo® buffer just before use. 40 µl of cell 
lysate from each sample was carefully transferred into 96-well clear bottom Castor 
plate without producing bubbles. 40 µl of LAR II  and Stop & Glo® reagents were 
added sequentially into the same sample and the each luciferase acitivity was read by 
BIO-TEK Synergy HT multiwell plate reader. 
 
To confirm the expression of NPAS3, ∆NPAS3, SOX5, SOX6, SOX9 and SOX10, 
total RNA of the cells were extracted and reverse transcripted into cDNA. QPCR 
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was carried out as decribed above. 18sRNA was used for the reference gene in the 
QPCR. 
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2.5 Illumina microarray analysis 
2.5.1  SOX11 cloning 
The SOX11 gene was cloned using the Invitrogen Gateway system. The human 
SOX11 open reading frame was amplified from SH-SY5Y cell lines using SOX11 
primers (table 2.1) containing attB sites and then cloned into the intermediate vector 
pDONR and then, subsequently, into the pDEST40 mammalian expression vector. 
Sequence verification of the clone was performed using a BigDye Terminator Cycle 
Sequencing Kit.  
2.5.2 Transient transfection of SOX11 gene into HEK293 cells 
HEK293 cells were cultured in DMEM (Invitrogen, Carsbad, CA) supplemented 
with 10% fetal bovine serum (Lab Tech Int.) at 37 0C in an atmosphere of 5% CO2 in 
humidified air. The culture medium was replaced by OPTI-MEM (OMEM) and then 
the HEK293 cells were transiently transfected by pDEST40-SOX11 or control 
plasmid (pDEST40) using lipofectamineTM 2000 transfection kit (Invitrogen) 
according to the manufacturer’s instructions. After 4-6 hours, the transfection 
medium was replaced with standard culture medium. Cells were removed using 
trypsin/versene at 24 hours post-transfection, washed in cold PBS and then frozen at 
-80oC. 
 
SH-SY5Y cells were also cultured and transiently transfected in the same manner for 
the western blot experiments. 
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2.5.3 Transient tranfection SOXD/E into HEK293 cells 
SOXD/E expression constructs were generously gifted by Chuanju Liu 
(SOX5/SOX6/SOX9) and Fabien Murisier/Friedrich Beerman (SOX10). All 
SOXD/E microarray experiments were carried out as transient transfections of 
HEK293 cells using Optimem/Lipofectamine 2000/plasmid DNA (Invitrogen) 
incubation for 6 hours followed by 24 hours in standard culture conditions. HEK293 
cells were maintained in DMEM supplemented with 10% Foetal Bovine Serum. 
 
2.5.4 Preparation of stable FLNPAS3/∆NPAS3 overexpression sample 
The full-length NPAS3 open reading frame (acc. NM_001164749) cloned into the 
pCDNA expression plasmid was a gift from Dr. Nicholas Brandon, Merck, Sharpe 
and Dohme, now at Wyeth. This was transferred into a similar TET-inducible 
expression plasmid (pT-REx-DEST30, Invitrogen, UK) using a restriction digest, 
Gateway (Invitrogen) cloning linker ligation and the BP/LR reactions (Invitrogen). 
The truncated form, ∆NPAS3, was generated by cleavage and removal of sequence 
between internal and multiple cloning site XhoI sites thus deleting the second PAS 
domain and the putative transactivation domain. After linearisation and transfection 
of FLNPAS3 and ∆NPAS3 plasmids into HEK293 [T-REx-293] cells (Invitrogen), 
selection for stable integration was achieved with Geneticin and Blasticidin; the latter 
to maintain the activity of the TET repressor-expressing pcDNA-6/TR plasmid 
already present within the cell line.  
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2.5.5 In vitro circadian induction by serum shock method 
For circadian induction, cells were washed in DMEM alone and then maintained in 
the same for 36 hours. In order to confirm the success of circadian rhythm induction, 
at zero hour time-point, HEK293 cells were shifted into a DMEM with 50% horse 
serum for 2 hours incubation. At +2 hours, HEK293 cells were washed with serum 
free DMEM and cultured with the same medium for the remaining experiment. Cell 
samples were collected every 4 hours. Gene expression levels of several circadian 
genes were determined by RT-PCR and Agarose gel electrophoresis. DNA binds 
were scaned by BIO-TEK Synergy HT soft ware. 
 
For microarray analysis, at the zero hour time-point, the cell medium was replaced 
with DMEM supplemented with 50% horse serum plus tetracycline in order to 
induce circadian cycling and NPAS3 over-expression (Balsalobre et al., 1998; Huang 
et al., 2009). At +2 hours, cells were washed with DMEM and then incubated with 
the same plus tetracycline for the remaining period of the experiment. Cells were 
collected at either +12 or +24 hours and frozen as above. In order  
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Figure 2.2 The induction of circadian rhythm in cultured cells by serum shock 
method. 
All experimental cells were removed from flasks by incubation with trypsin/versene, 
washed in cold phosphate buffered saline and then immediately frozen at -80oC. 
 
2.5.6 Total RNA extraction 
Extraction of total RNA from transfected and control cells was performed with the 
mini RNeasy Kit (Qiagen, Valencia, CA) according to the manufacturer’s 
instructions. The purity and integrity of each total RNA sample was monitored using 
the Agilent 2100 bioanalyzer (Agilent Technologies, Palo Alto, CA). The ratio of 
A260 to A280 values of each sample, an effective measure of RNA purity, fell in the 
range of 1.8-2.1 indicating high purity. The RNA integrity number (RIN) of each 
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sample was also evaluated using the Agilent 2100 bioanalyzer. Only RNA samples 
which demonstrated RIN values above 9.5 were used for probe synthesis purposes. 
 
2.5.7 cRNA probe preparation 
Biotinylated cRNA was prepared using the Illumina total Prep RNA application Kits 
(Ambion. Inc., Austin, TX) according to the manufacturer’s direction starting with 
100ng total RNA. The size of cRNA was evaluated using Agilent 2100 bioanalyzer. 
The cRNA profile of each sample was distributed from 250-5500 bp with most of the 
cRNA at 1000-1500 bp. All cRNA samples passed the quality filter and met our 
criteria for inclusion into further Illumina Beadarray analysis. 
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2.5.8 Illumina microarray 
For NPAS3 experiments parental HEK293 [T-REx-293] cells were used as negative 
controls because stably integrated FLNPAS3/∆NPAS3 cell lines showed a low level 
of leaky transcription in the absence of tetracycline. In the SOX microarray studies, 
Quadruplicate transient transfections of pDEST40 plasmid were used as controls 
were used as shared negative controls compared to triplicate transfections with each 
of the SOX expression constructs. For all standard cell culture experiments with 
FLNPAS3/∆NPAS3/parental negative control cell lines, duplicate biological samples 
were assessed. 
 
An Illumina Beadstation platform was used in conjunction with Sentrix® 
HumanRef-8 v1 and v2 chips (Illumina, Inc., San Diego, CA) capable of examining 
expression of over 24,500 gene transcripts. Hybridization, washing and scanning 
were performed according to the Illumina BeadStation 500* manual (revision C) by 
experienced staff located within the Genetics Core of the Wellcome Trust Clinical 
Research Facility at the Western General Hospital, Edinburgh. Three control 
replicates and 3 SOX11 transient transfection replicates were carried out on one 




2.5.9 Analysis of microarray data  
For the investigation of the SOX11 regulatory profile, expression differences 
between the cell lines were assessed using two Bioconductor (Gentleman et al., 2004) 
algorithms implemented in the statistical programming language, R. Genes 
differentially expressed between cell-line samples were identified using limma  (this 
part of work was performed by Robert Kitchen) and SAM (Signifacance analysis of 
Microarray) (Tusher et al., 2001). The latter was implemented as part of the BRB-
ArrayTools (3.70) freeware developed by the Biometric Research branch of the US 
National Cancer Institute (http://linus.nci.nih.gov/BRB-Arraytools.html). In both 
analyses, the Illumina probe profile expression data were log-transformed and 
normalised using quantile normalisation. For the analysis using the limma package, 
genes were defined as being differentially expressed after satisfying a minimum fold-
change of ±1.5 and a maximum, Benjamini-Hochberg adjusted, p-value of 0.01. For 
the SAM analysis, the differentially expressed genes were selected at a maximum 
predicted false discovery rate of 0.01. 
 
For NPAS3 and SOXD/E microarray analysis, microarray data analysis was carried 
out using BRB-ArrayTools 3.8.0 freeware and included normalisation and log 
transformation of raw data followed by hierarchical clustering of samples, 
identification of statistically significantly up- or down-regulated genes through 
Statistical Analysis of Microarrays (SAM).  
 
Regulated genes were further categorised by bioinformatics tools such as Ingenuity 
Pathway Analysis (Ingenuity systems 
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https://analysis.ingenuity.com/pa/login/applet.jsp) and GeneCodis2 for particular 
gene ontologies, biological processes, and associated canonical pathways. 
 
2.5.10 Confirmation by Q-RTPCR 
Quantitative reverse transcriptase PCR (QPCR) was used to validate mircroarray 
results using the same set of RNA and also measure time-dependent changes in gene 
expression levels due to Sox11 over-expression at 0h, 3h, 6h, 12h and 24h and 48h of 
transient transfection. Briefly, the total RNA of HEK293 cells were purified with 
RNeasy columns (Qiagen). This RNA served as template for oligo-dT-primed cDNA 
synthesis with reverse Transcriptase (Roche). QPCR was performed with SYBR 
green QPCR Master Mix (Invitrogen) and a Real-Time QPCR machine (BIO-RAD). 
For relative quantification of mRNA expression, geometric means were calculated 
using the comparative double delta method described previously (Dracheva et al, 
2005). Primers used in QPCR were designed using Primer3 Software and sequences 
are included in table 2,1. The gene expression levels of housekeeping gene (GAPDH) 
in SOX11 overexpressing cells and control cells are similar, so this gene was 
selected as the endogenous references in this QPCR study. Sample concentrations 
were normalized to GAPDH according to the respective ratios of GAPDH levels per 
HEK293 cell sample, with 3 replicates per time point. Student’s T-test was used to 






In the FL/∆NPAS3 microarray studies, as GAPDH was found upregulated by 
FL/∆NPAS3 when comparing its expression in control cells, it could not be used as a 
reference gene. The expression levels of 18sRNA, one housekeeping gene, are 
similar in FL/∆NPAS3 overexpressing and control cells, so it was selected as the 
endogenous references in the confirmation of genes targeted by FL/∆NPAS3 by 
QPCR assay.  Sample concentrations were normalized. Three experimental replicates 
were used. Student’s T-test was used to determine significant at each time point and 
changes of P<0.05 were considered significant. 
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2.5.11 Confirmation by Western 
Samples prepared from HEK293 cells and SH-SY5Y cells were subjected to SDS-
PAGE gel electrophoresis (NuPAGE® Novex® Tris-Acetate gels). Protein was 
transferred to 0.2 µm Polyvinylidene Difluoride (PVDF) membrane (Invitrogen), 
blocked in 5% dried milk powder in 50 mM Tris-HCl, pH 7.5, 15 mM NaCl, 0.5% 
Tween-20 (TBST), washed briefly in TBST several times for 1 hour and incubated in 
primary antibody solutions in 2% donkey serum, and incubated in these solutions for 
overnight  at 4 °C. The following antibody solutions and dilutions were used: 1/1000 
SOX11 rabbit anti human, 1/1000 YWHAZ rabbit anti human, 1/800 SCG2 goat anti 
human (Santa Cruz Biotechnology) and 1/800 TUBB3 rabbit anti human (Abcam®) 
Blots were then washed 3 times in TBST, incubated for 1 hour in anti-rabbit horse 
radish peroxidase-conjugated secondary antibody (1 1000 in TBST), washed 3 times 
in TBST and incubated in ECL plus Western blotting detection reagent for 1-5 
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3 Transcriptional regulation by a psychiatric candidate gene-
NPAS3 
3.1 Introduction 
In this chapter, I will use immunofluorescence and gene microarrays to explore the 
function of NPAS3. As the Npas3 deficient animal model shows a deficit in 
neurogenesis, NPAS3 was suggested to be involved in the regulation of new neuron 
production. In order to determine the spatio-temporal contribution of NPAS3 to adult 
neurogenesis, co-staining with several known neurogenesis markers in the adult 
mouse hippocampus was carried out using immunofluorescence. 
 
Based on the role of NPAS3 in adult hippocampus neurogenesis and its contribution 
to schizophrenia, bipolar disorder and major depression, we supposed that the 
regulatory profile of NPAS3 might provide valuable clues to better understand the 
underlying pathological mechanisms of psychiatric illness. 
 
The regulatory profiles of full-length (FLNPAS3) and artificially truncated (∆NPAS3) 
forms of NPAS3, were indentified by Illumina microarray analysis in an in vitro 
system, the human embryonic kidney cell line (HEK293). ∆NPAS3 was generated by 
cleavage at an XhoI site which removes the second PAS domain and the putative 
transactivation domain. Thus, the properties of the bHLH domain and transactivation 
domain can be identified by comparing of the regulatory profiles of FLNPAS3 and 
∆NPAS3. Biostatistical software (BRB), QPCR validation and gene ontological 




3.2.1 Npas3 expression in mouse brain supports a direct role in 
neurogenesis 
The expression pattern of Npas3 in the adult mouse hippocampus was investigated 
using immunofluorescence microscopy. The sections from frozen mouse brain were 
cut using a Thermo cryostat. The following antibody solutions and dilutions were 
used: 1/400 Npas3 goat anti mouse, 1/400 Dcx rabbit anti mouse, 1/400 Gfap rabbit 
anti mouse, 1/500 Nestin rabbit anti mouse, (Santa Cruz Biotechnology). Npas3 is 
strongly expressed in the sub-granular zone of the dentate gyrus with processes 
radiating into the granule cell layer proper (Figure 3.1). Npas3 has a lower 
expression level in other brain regions, including ependymal cells and axo-dendritic 
regions adjacent to the cell soma in many cortical neurons (data are not shown).  
 
To define the specific stage at which Npas3 exerts its function during neurogenesis, 
several neurogenesis markers, including Dcx, Gfap and Nestin, were co-stained with 
Npas3 in the hippocampus in the adult mouse brain. Npas3 was found to colocalise 
with Dcx, but not other markers of neurogenesis in the adult mouse hippocampus. 
This suggests that NPAS3 might exert its function at the same stage in development 
as Dcx, which has a role in converting progenitors into mature granule cells. This 












































































































































































































































































































































































































































































































3.2.2 NPAS3 target genes in standard culture conditions 
Illumina microarray analysis was carried out to investigate the gene expression 
changes in HEK293 cells after over-expressing FLNPAS3 and ∆NPAS3. The 
fragments of FLNPAS3 and ∆NPAS3 were transferred into a similar TET-inducible 
expression plasmid and transfected into HEK293 [T-REx-293] cells (Invitrogen). 
Selection for stable integration was achieved with Geneticin and Blasticidin. Parental 
HEK293 [T-REx-293] cells were used as negative controls because stably integrated 
FLNPAS3/∆NPAS3 cell lines showed a low level of leaky transcription in the 
absence of tetracycline. Duplicate biological samples were assessed for all standard 
cell culture experiments with FLNPAS3, ∆NPAS3 or parental negative control cell 
lines. Microarray probes synthesised from RNA extraction products were quantified 
using an Agilent Bioanalyzer to ensure high quality probes of equal quantity between 
experiments. Sentrix® HumanRef-8 v2 chips (capable of examining expression of 
over 24,500 gene transcripts) were used to detect gene expression profiles.  
 
BRB analysis software was used to statistically analyse gene expression among the 
22,177 well annotated RefSeq transcripts present in each array. Unsupervised 
hierarchical clustering of microarray gene expression profiles using centred 
correlation and average linkage revealed related transcriptional profiles for 
FLNPAS3 and ∆NPAS3 over-expression samples but distinct from control samples 
(Figure 3.2)  
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Figure 3.2 Hierarchical clustering dendrogram illustrating relationships between FLNPAS3, 
∆NPAS3 and control HEK293 cell microarray data. Using centered correlation and average 
linkage, two distinct clusters corresponding to FL/∆NPAS3 over-expressed and control cells 
were revealed. Thus FL/∆NPAS3 over-expression induces a reproducible and global change 
in gene expression. Control1-2:AVG, HEK293 parental cell line treated with tetracycline; 
NPAS3a/b:AVG, Tetracycline-induced FLNPAS3 over-expression in a HEK293 cell line, 
∆NPAS3a/b:AVG, Tetracycline-induced ∆NPAS3 over-expression in a HEK293 cell line. 
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3.2.3 Genes regulated by FLNPAS3 in standard conditions 
Microarray data was filtered using the SAM algorithm (Significance Analysis of 
Microarrays) with a 0.01 target proportion of false discoveries and 100 permutations. 
3476 genes were found to discriminate between FLNPAS3 and control. In a 
univariate comparison test (applying a random variance model) between control and 
FLNPAS3 microarray experiments, 282 genes showed >=1.5-fold up-regulation by 
FLNPAS3 and 359 genes were similarly down-regulated.  
 
As the oligonucleotide probe for NPAS3 is complementary to 3’sequence, which is 
deleted in ∆NPAS3, NPAS3 was only found in the FLNPAS3 data list with the top 
up-regulated gene (69-fold) (Table 3.1). This result further confirms the over-














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.2.4 Comparison of FLNPAS3 and ∆NPAS3 regulation 
In order to compare the regulatory activities of FLNPAS3 and ∆NPAS3, the fold 
change of genes regulated by both FLNPAS3 and ∆NPAS3 were plotted against each 
other in Excel. There was substantial correlation of target gene fold-change between 
FLNPAS3 and ∆NPAS3 cells in standard culture conditions, with linear regression r2 
values of 0.59 (up-regulated genes) and 0.78 (down-regulated genes). These results 
suggest that FLNPAS3 and ∆NPAS3 have the same transcription activity in the 
standard conditions. This result is very surprising because the ∆NPAS3 does not retain 



















Inverse fold-change for shared up-regulated genes
R2 = 0.5899





























Fold-change for shared down-regulated genes
R2 = 0.781


























 Figure 3.3  FLNPAS3 and ∆NPAS3 shared target gene regulation is highly correlated under 
standard cell culture conditions indicating minimal effect of truncation.  A) up-regulated 
genes. B) down-regulated genes. All expression data is log transformed and normalised as 













3.2.5 Confirmation of our FLNPAS3/ ∆NPAS3 microarray findings 
In order to validate our microarray findings, QPCR analysis was carried out on 
several selected genes using the same RNA used in our microarray experiment. The 
QPCR reactions were performed in triplicate and Double delta method was used to 
calculate the gene expression level. VGF, HK2, ENO2, and SOX11 showed similar 
fold changes in QPCR and microarray assays (Figure 3.4). These target genes were 
chosen because: a) they are in the top list of regulated genes, (VGF, HK2 and ENO2); 
b) they are relevant to the function of glycolysis and hypoxia (ENO2, HK2); c) they 





Figure 3.4 QPCR verification of microarray findings.  
Expression of VGF, HK2, ENO2 and SOX11 was determined by triplicated QPCR 
analysis of the RNA used in the microarray assays. Gene 18sRNA was used to 
normalise data from FLNPAS3 and ∆NPAS3 (dNPAS3) over-expression samples 
and values are expressed as fold-change in gene expression in comparison to the 





3.2.6 The relevant functions of up-regulated genes 
The up-regulated set of genes were examined using the online tool GeneCodis2 
(Nogales-Cadenas et al., 2009) to investigate relevant biological processes. Thirty-
six of the 282 up-regulated genes (corrected hypergeometric p-value = 2.07 X 10-8) 
were categorised by the gene ontology term ‘transcription’ (GO:0006350) being 
either transcription factors or DNA-binding proteins with regulatory function. An 
interacting network of transcription factors is a common feature of developmental 
biological programmes including neurogenesis. 
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3.2.7 The function analysis of down-regulated genes 
3.2.7.1 Several SOX family genes are negatively regulated by NPAS3 
In our microarray data list, three members of the SOX family of transcription factors, 
SOX3, SOX11 and SOX12, were down-regulated by NPAS3. The expression levels of 
these genes were further analysed using QPCR on FLNPAS3 over-expressed and 
control HEK293 cells. Triplicated reaction and double delta method were performed 
(Figure 3.5). SOX3 is a marker of neural progenitor proliferation (Axell et al., 2009) 
and SOX11 is a master-regulator of neuronal differentiation (Azuma et al., 1999; 
Bergsland et al., 2006; Dy et al., 2008; Hargrave et al., 1997; Haslinger et al., 2009). 
Both the microarray and QPCR results provide evidence for a direct interaction of 










Figure 3.5  Three SOX family genes, SOX4, SOX3 and SOX11, were down-regulated in 
FLNPAS3 over-expressing HEK293 cells. Expression of these genes was verified by 
triplicated QPCR analysis of the same RNA used in the microarray assays. 
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3.2.7.2 Functional analysis of down-regulated genes by IPA and 
Genecodis2 
In order to assess the principal biological functions or gene classes over-represented 
in the down-regulated genes, Ingenuity Pathway Analysis (IPA) and Genecodis2 
were selected to run the microarray data. 
 
The networks illustrate functional relationships between gene products based on 
published interactions in the literature. The scores for the networks were calculated 
based on the number of network eligible genes and the size of the network. This 
provides an estimate of the relevance of any particular network was to the total list of 
eligible genes. IPA identified five significant pathways (Table.3.7): 
glycolysis/gluconeogenesis (16 genes, p=6.14 X 10-6), ERK/MAPK signalling (16 
genes, p=8.67 X 10-3), Neuregulin signalling (9 genes, p=2.35 X 10-2), Notch 
signalling (6 genes, p=2.37 X 10-2), and Circadian rhythm signalling (4 genes, 
p=4.16 X 10-2). Full IPA analysis is presented in the Tables 3.3-3.7.  
 
Using GeneCodis2, 8 genes of the glycolysis pathway (GO:0006096) were of 
greatest significance (corrected hypergeometric p-value = 5.21 X 10-7) Figure 3.6 
Additionally, 21 genes participating in the ‘oxidation:reduction’ biological process 
(GO:0055114) were also significantly down-regulated (p = 6.30 X 10-7). Together, 
these findings strongly suggest that NPAS3 is involved in the regulation of anaerobic 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.6 Most glycolytic enzyme genes are down-regulated in the presence of NPAS3. Fold change 
in expression is shown in green next to each gene. The up-regulation of Lactate Dehydrogenase (LDH) 






3.2.8 Histone and zinc finger genes and chromosomal domain 
regulation by NPAS3 
In order to detect whether some NPAS3 regulated genes lie in clusters on 
chromosomes, the microarray data were plotted according to chromosome order. 
Strikingly, seven histone genes were down-regulated by overexpression of NPAS3: 
HIST2H2BF, HIST2H4A, HIST2H3C, HIST2H2AA3, HIST2H2BE, HIST2H2AC, and 
HIST2H2AB. Closer inspection showed that many were present within a cluster on 
chromosome 1. This suggests that the transcriptional effects of NPAS3 might be 
indirect in some circumstances: mediated through the alteration of regional 









Figure 3.7 NPAS3 regulates the expression of a cluster of histone genes located on 
chromosome 1. A sliding window analysis of average expression change of genes ordered 
along each chromosome (Chromosome 1 to the extreme left, X then Y to the right. Red lines 
represent chromosome boundaries). Expression is displayed as a positive fold-change here 
but represents down-regulation of the genes in reality. The peak on chromosome 1 
corresponds to a cluster of histone genes. This region is expanded above where fold-change 
down-regulation of individual genes is plotted. The down-regulated cluster consists of: 
HIST2H2BF, LOC653604, HIST2H4A, HIST2H3C, HIST2H2AA3, HIST2H2BE, 
HIST2H2AC, and HIST2H2AB. 
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3.3 Discussion 
Previously, Erbel-Sieler and colleagues had reported that Npas3 was expressed in 
brain inhibitory interneurons (Erbel-Sieler et al., 2004). In our results, Npas3 was 
expressed in the inner site of dentate gyrus, where neurogenesis takes place. 
Strikingly, Npas3 is co-expressed with Doublecortin (Dcx) (not other neurogeneis 
markers) in the dentate gyrus (Figure 3.1 and 3.8), which supports an 
intermediate/maturation role in the neurogenic process (Kerjan et al., 2009).  This 





Figure 3.8 Dcx is a neurogenetic marker during the process of converting progenitors 
into immature granule cell. (Adapted from Halbach, 2007) 
 
The regulatory profiles of FLNPAS3 and ∆NPAS3 are highly similar. Only one gene, 
OST-alpha, encoding an organic solute transporter, displayed down-regulation 
specific to FLNPAS3. These observations match those from a study of the related 
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bHLH transcription factor, ARNT, which indicated that dimerisation and 
transcriptional regulation functions were largely preserved in a C-terminal deletion 
form analogous to ∆NPAS3 - lacking the second PAS and transactivation domains 
(Reisz-Porszasz et al., 1994). 
 
Glycolysis is the metabolic pathway that converts glucose into pyruvate thus 
releasing energy to form ATP and NADH. Glucose is the primary source of energy 
for the brain. Hence, glucose metabolism, or glycolysis, influences biological process 
in the brain. Dysfunction of glysolysis results in an inability for the cell to respire 
and therefore cause the apoptosis of the cell at an early stage. Glycolysis is deranged 
in a variety of disorders of the nervous system, including Huntington’s disease 
(Oliveira, 2010), Alzheimer’s disease (Brinton, 2008; Gibson et al., 1998) and 
depression (Talisman and Marzabadi, 2008). Our microarray findings show that 
many genes in the glycolysis pathway are negatively regulated by NPAS3. This may 
provide the underlying mechanism for the abnormalities in brain structure and adult 
neurogenesis found in psychiatric illness.  
 
The microarray data also revealed another role for NPAS3 in the regulation of 
hypoxic response. Brain hypoxia has been proposed as a risk factor for the 
development of schizophrenia (Handford, 1975; Prabakaran et al., 2004; Van Erp et 
al., 2002). Under hypoxia conditions, energy metabolism is changed (Webster, 2003). 
In our microarray data, NPAS3 was shown to be involved in the reduced expression 
of many hypoxia responsive genes (Table 3.2). I hypothese that although the 
concentration of oxygen in the brain may remain normal, the expression of hypoxia 
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responsive genes can still be increased in the brain of individuals with schizophrenia, 
who have a deletion of NPAS3 gene.  
 
More details about the role of NPAS3 in glycolysis, circadian rhythm and hypoxia 



























4 Comparison of NPAS3 with SOX transcription factors 
4.1 Introduction  
The molecular processes regulating the proliferation of progenitor cells followed by 
their differentiation into functional neurons has been the subject of much study – 
particularly in relation to adult neurogenesis. As discussed in the chapter 3, NPAS3 
colocalised with Dcx (doublecortin) in the dentate gyrus of adult mouse brain. This 
supports the hypothesis that NPAS3 might exert its function during the later stages of 
neurogeneis. If this is true then the original interpretation of the knockout model that 
Npas3 deletion causes a failure in proliferation is incorrect, instead it is possible that 
NPAS3 deletion causes a loss of neurogenesis (through apoptosis) during the 
differentiation phase. The aim of this section is to identify the genes regulated by 
NPAS3 for clues about its role in neurogenesis. To place NPAS3 in the context of 
known regulators of neuronal differentiation, the regulatory profiles of NPAS3 and 
the SOX family of transcription factors were compared. 
4.1.1 Sox family genes 
4.1.1.1 The structure of Sox family gene 
Sry box-containing (Sox) family of transcription factors bind sequence-specifically 
to the minor groove in DNA by means of a conserved high-mobility group (HMG) 
domain. Sox genes are defined as containing the HMG box of a gene, Sry. Sry (Sex-
determining Region Y) is a sex determining gene containing HMG-box on the Y 
chromosome  in the placental mammals and marsupials (Wallis et al., 2008). The 
HMG box domain contains three alpha helices separated by loops (Thomas, 2001). 
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Proteins containing HMG domain are involved in the regulation of DNA-dependent 
processes, including transcription, replication and DNA repair through changing the 
conformation of chromatin (Thomas, 2001). 
4.1.1.2 The classification of the Sox genes 
Based on phylogenetic analysis of this HMG domain, Sox factors can be separated 
into several subgroups; A-H subgroup are represented in mouse and human (Bowles 
et al., 2000). Members of the Sox family of genes have diverse functions during the 
development and differentiation of multiple organ systems (Pevny and Placzek, 
2005).  
• SoxA: SRY 
• SoxB1: SOX1, SOX2, SOX3 
• SoxB2: SOX14, SOX21 
• SoxC: SOX4, SOX11, SOX12 
• SoxD: SOX5, SOX6, SOX13 
• SoxE: SOX8, SOX9, SOX10 
• SoxF: SOX7, SOX17, SOX18 
• SoxG: SOX15 
• SoxH: SOX30 
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4.1.1.3 The location of Sox genes 
Several Sox genes are expressed in adult human brain (Table 4.1) and appear to 
regulate differentiation and cell fate in a cell type specific manner (Cahoy et al., 
2008). Sox proteins are found to form stable transcription complexes with a wide 
range of transcription factor proteins, either to activate or repress transcription 
(Wilson and Koopman, 2002). 
 
Table 4.1 Sox proteins and their locations in human brain 
Sox proteins Locations in brain Partners 
Sox2 Developing neurons, oligodendrocytes, astrocytes 
and high in adult astrocytes 
 
Sox5 Very high in developing oligodendrocytes and high 
in adult astrocytes 
Sox6 
Sox6 Very high in developing oligodendrocytes and high 
in adult astrocytes 
CtBP1 
Sox7 Adult neurons  
Sox9 High in astrocytes SF1, HSP70 
Sox10 High in oligodendrocytes Pax3, 
EGR2, 
Krox-20 
Sox11 Developing neurons/oligodendrocytes/astrocytes Brn-1 
Sox17 Adult neurons  
Sox21 Developing neurons/oligodendrocytes/astrocytes and 
high in adult astrocytes 
 
4.1.1.4 The functions of different Sox groups. 
SRY (A-group Sox factor) initiates male sex determination. Mutations in this gene 
cause XY female (Swyer syndrome) (Shahid et al., 2008), while translocation of this 
gene to the X chromosome results in XX male syndrome (Wallis et al., 2008). SRY 
proteins are reported to link to dopamine-related diseases, including schizophrenia 
and Parkinson’s disease through control of the concentrations of dopamine (Dewing 
et al., 2006). 
 132
B-group Sox factors play an important role in the processing of progenitors in 
neurogenesis (Figure 4.1). Sox B1 members, Sox1, Sox2 and Sox3 are expressed in 
most neuronal progenitors to maintain the pluripotent identity of progenitor cells and 
thus prevent cells from entering a differentiated state (Bylund et al., 2003). Sox21, a 
member of SoxB2 family, inhibits the function of SoxB1 members and initiates a 
programme of differentiation in cells (Sandberg et al., 2005). 
 
Sox C members, including Sox4, Sox11 and Sox12, possibly play a key role during 
the regulation of later aspects of neurogenesis (Figure 4.1). They are mainly 
expressed in neuronal cells which have been committed to neuronal differentiation 
(Cheung et al., 2000). Sox4 and Sox11 regulate the establishment of pan-neuronal 
protein expression by inducing precocious expression of neuronal markers in self-
renewing precursors (Bergsland et al., 2006). 
 
SoxD and SoxE proteins regulate multiple stages of oligodendrocyte specification 
and differentiation (Stolt et al., 2006). Members of group E (Sox9 and Sox10) are 
required during specification and terminal differentiation in the oligodendrocyte 
precursors (Finzsch et al., 2008). Whereas, two D-group genes (Sox 5 and Sox6) 
negatively regulate Sox E genes, and so maintain the pluripotent identity of 



























































4.1.1.5 The SOXD and SOXE memebers 
The SOXD group is composed of 3 members, SOX5, SOX6 and SOX13. They 
contain two highly conserved functional domains: the HMG box in the C-terminal 
and a group-specific coiled-coil in the N-terminal ends, which mediates the 
dimerization of the SOXD proteins with other (Lefebvre et al., 1998).  Both SOX5 
and SOX6 are highly expressed in spermatids, neurons, oligodendrocytes and 
chondrocyte (Connor et al., 1995; Denny et al., 1992; Lefebvre et al., 1998; Stolt et 
al., 2006).  SOX5 and SOX6 are co-express with SOXE proteins in chondrocytes, 
oligodendrocytes and melanocytes. The SOXD proteins have no known 
transactivation or transrepression domain, but they are involved in transcriptional 
regulation. The human SOX5 is expressed as long transcripts (6 kb) in the tissues 
except testis. SOX5 and SOX6 not only can facilitate SOX9 in activating many 
genes’ expression (Han and Lefebvre, 2008), but also can block the transactivation 
ablility of SOX9 and SOX10 by competing with these proteins for binding to the 
promoters of different markers (Stolt et al., 2006). 
  






Mutations in SOX9 and SOX10 genes result in the neural defects and neurological 
symptoms of Campomelic Dysplasis, Waardenburg-Hirschsprung and PCWH 
syndromes. In schizophrenia patients, increased DNA methylation of SOX10 was 
linked to oligodendrocyte dysfunction (Schlierf et al., 2006). It was also reported  
that association evidence provisionally supports roles for SOX5 in metabolic side-
effects of antipsychotic treatment (Adkins et al., ; Adkins et al., 2010) and SOX10 in 
increased risk of psychiatric illness (Maeno et al., 2007). 
 
SOXD and SOXE proteins regulate multiple stages of oligodendrocyte specification 
and differentiatiom. Members of group E (Sox9 and Sox10) are required during 
specification and terminal differentiation in the oligodendrocyte precursors. Whereas, 
two D-group genes (Sox 5 and Sox6) negatively regulate Sox E genes, and so 
maintain the pluripotent identity of oligodendrocyte progenitors. (Azim et al., 2009; 
Bergsland et al., 2006; Cheung and Briscoe, 2003; Hamada-Kanazawa et al., 2004; 
Haslinger et al., 2009; Kim et al., 2003; Kwan et al., 2008; Lefebvre, 2009; Prior and 
Walter, 1996). It was also reported that SOX5 is involved in the metabolic side-
effects of antipsychiotic treatment (Adkins et al., ; Adkins et al., 2010) and SOX10 is 
associated with the increased risk of psychiatric illness (Maeno et al., 2007). All of 
these evidences support the possibility that NPAS3 might be relevant to the network 






4.2 Aims of this study 
We investigated the regulatory profile of SOX5 and SOX6 (SOX D group), SOX9 
and SOX10 (SOX E group), and SOX11 by Illumina microarray. SOX factors were 
inserted into pDEST40 plasmids and transiently transfected into triplicate HEK293 
cells using Optimem/Lipofectamine 2000. After 24 hours, (6 hour incubation with 
transfection mix followed 24 hrs in standard culture condition), the cells were 
collected and used for the probe synthesis. Quadruplicate transient transfections of 
pDEST40 plasmid were used as controls. Sentrix® HumanRef-8 v2 chips (capable of 
examining expression of over 24,500 gene transcripts) were used to detect gene 
















4.3.1 Genes regulated by SOX5 in HEK293 cells 
Illumina microarray analysis was carried out to investigate the consequences of 
SOX5 overexpression in HEK293 cells. BRB analysis software was used to analyse 
the expression of the 22,177 well annotated RefSeq transcripts present in each array. 
Microarray data was also filtered using the SAM algorithm (Significance Analysis of 
Microarrays). 688 genes were found to discriminate between cells overexpressing 
SOX5 and controls. The estimated false discovery rate among the 688 genes was 
0.09. In a univariate comparison test (applying a random variance model) between 
control and SOX5 microarray experiments, 44 genes showed >=1.5-fold up-
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4.3.2 Genes regulated by SOX6 in HEK293 cells 
The gene expression of SOX6 overexpressed and control HEK293 cells were 
identified by Illumina microarray and further used BRB analysis software to 
statistically analyse gene expression among the 22,177 well annotated RefSeq 
transcripts present in each array. 2085 genes were identified using SAM, the 
estimated false discovery rate among the 2085 genes was 0.01. 46 genes regulated by 
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4.3.3 Gene regulated by SOX9 in HEK293 cells 
To investigate the gene expression of SOX10 overexpressed and control HEK293 
cells, Illumina microarray analysis was carried out. BRB analysis software was used 
to analyse the expression of the 22,177 well annotated RefSeq transcripts present in 
each array. Microarray data was also filtered using the SAM algorithm (Significance 
Analysis of Microarrays). 311 genes were identified using the software SAM, the 
estimated false discovery rate among the 311 genes was 0.001. 89 genes regulated by 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.3.4 Gene regulated by SOX10 in HEK293 cells 
Illumina microarray analysis and BRB analysis software were used to investigate the 
gene expression of SOX10 overexpressed and control HEK293 cells. Microarray 
data was also filtered using the SAM algorithm (Significance Analysis of 
Microarrays). There are 111 genes significant by SAM, the estimated false discovery 
rate among the 111 genes is 0.01. 37 SOX10 regulated genes with a fold 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.3.5 Shared targets of NPAS3 and SOX factors 
In order to identify the overlap of transcriptional targets between the NPAS3 and 
SOX factors, the up-regulated genes of NPAS3 were compared with those from 
SOX5, SOX6, SOX9 and SOX10. Two observations were made from these data. 
Firstly, the related pairs of SOX genes showed a greater overlap with each other than 
with NPAS3, confirming functional conservation and established redundancy. 
Secondly, SOX5 and SOX6 have a greater numerical overlap with NPAS3 than 
SOX9/SOX10 but a similar proportion. Genes regulated by SOX5/6 and by NPAS3 
included VGF, NEFH, MGC14376, C19orf30, DNAH17, CHGA, HIST1H4H, 
GADD45B, DPH2, and GALR2. Genes regulated by SOX9/10 and by NPAS3 
included PLA2G4C, C1orf162, GALR2, CARD9, OVGP1, SBSN, CELSR3, and 
CLK1.  
 
The most significantly up-regulated gene by NPAS3, SOX5 and SOX6 was VGF 
encoding a precursor for a number of processed and secreted signalling peptides such 
as TLQP-21. Vgf studies in the mouse have produced compelling evidence that it 
mediates the connection between physical activity, increased adult neurogenesis and 
attenuation of depression-like phenotypes. VGF peptides have also been associated 
with the regulation of metabolic rate matching the metabolic aspect of NPAS3’s 
function. VGF and other neuropeptides such as secretogranin II and NPY are 
regulated in the hippocampus when voluntary exercise was employed as a mood 
stimulator. It was also reported that VGF peptide can produce a robust antidepressant 
response in a dose dependent manner in FST and tail suspension tests (Hunsberger et 
al., 2007). VGF was reported as an important factor in the central nervous system in 
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a peptidomic analysis on normal cerebrospinal fluid (CSF) (Yuan and Desiderio, 
2005). 
 
The highly conserved VGF gene encodes a 617 amino acids precursor polypeptide, 
which is then processed into more than 10 different mature peptides by 
neuroendocrine-specific prohormone convertases PC1/3 and PC2 (Possenti et al., 
1999; Trani et al., 2002). The most prominent mature VGF peptides are 20 (NAPP-
129) and 10kDa (TLQP-62).  VGF is expressed exclusively in neurons of several 
areas, such as the olfactory system, cerebral cortex, hypothalamus, hippocampus, the 
adrenal medulla and motor neurons of the spinal cord. VGF is a highly relevant 
target gene as it shares a number of key features with NPAS3; regulation by 
circadian rhythm (Cirelli and Tononi, 2000), involvement in metabolic control 
(Altshuler and Hirschhorn, 1999; Bartolomucci et al., 2006; Bartolomucci et al., 
2007; Jethwa and Ebling, 2008; Jethwa et al., 2007; Salton et al., 2000), contribution 
to activity-related adult neurogenesis (Thakker-Varia et al., 2007), and association 
with neurological diseases (Altar et al., 2009; Pasinetti et al., 2006; Ruetschi et al., 
2005; Selle et al., 2005) including depression (Hunsberger et al., 2007; Malberg and 
Monteggia, 2008; Thakker-Varia and Alder, 2009; Thakker-Varia et al., 2007) and 







We also observed a substantial overlap in target genes down-regulated both by 
NPAS3 and  SOX11 (data is also included on SOX11. the background to SOX11 is 
presented in Chapter 6). The most significant down-regulation with NPAS3 and 









































































































































































































4.3.6 Testing transcriptional control at the VGF promoter 
The VGF gene promoter contains several specific regions which are thought to be 
critical for the neuronal expression of VGF. These include a CREB binding site 
(Bonni et al., 1995), which is critical for BDNF-induced VGF expression, a CCAAT 
box, a G(S)G element and an E-box near the transcription start sites (D'Arcangelo et 
al., 1996). As it is known that basic helix-loop-helix domain transcription factors 
(such as NPAS3) bind specifically to E-box and VGF is a top upregulated gene of 
NPAS3 in our microarray data set, we can hypothesise that NPAS3 might activate 
the promoter of VGF. 
 
A human VGF promoter fragment, containing promoter, exon1, intron1 and part of 
exon2, was cloned into a pGL3 basic vector (Figure 4.4). The activity of the VGF 
promoter was analysed using a dual luciferase assay in FLNPAS3/∆NPAS3 
overexpression and control cells. The values of VGF promoter (Firefly luciferase) in 
each sample represent the percentage of the relative activity of the empty pRL-TK 
vector (Renilla luciferase). Data were analysed by one way ANOVA. In HEK293 
cells, the luciferase activities of VGF promoter are significantly different from each 
other in the NPAS3/∆NPAS3 over-expressed cells and control vector HEK293 cells 
(Figure 4.5 A). While, in SHSY-5Y cells, luciferase expression in the FLNPAS3 
over-expressed cells was significantly higher than ∆NPAS3 and control vector SH-
SY5Y cells (Figure 4.5 B). 
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Figure 4.4 The structure of human VGF promoter fragment.  
This fragment is a 2029bp sequence and includes 5’ untranslated part, exon1, intron1 
and part of exon2. E-box, which is specially recognised by NPAS3, is within the 5’ 








Figure 4.5 Luciferase expressions in the NPAS3 /∆NPAS3/control vector over-expressed 
cells. A: Luciferase expression in the NPAS3 /∆NPAS3/control vector over-expressed 
HEK293 cells.  
B: Luciferase expression in the NPAS3 /∆NPAS3/control vector over-expressed SH-SY5Y 
cells. The values represent the percentage of the relative activities to the pRL-TK vector 
(mean±SEM).  
Asterisks mean significantly different VGF promoter activities at P < 0.05 (*) or P < 0.01 




This study strongly suggests that NPAS3 participates in a neurodevelopmental 
regulatory network overlapping and interacting with the SOX transcription factor 
family. We propose that the overlap between NPAS3 and SOX target genes may 
reflect the intermediate position of NPAS3 in the neurogenic transcriptional 
programme dictating progression from neural progenitor, through fate-committed 
cell, to differentiated neuron. 
 
4.4.1 Genes with overlapping regulatory functions 
SCG2 protein is strongly up-regulated in our studies by SOX9, SOX10 and SOX11. 
SCG2 (Secretogranin II/Chromogranin-C) is a cell surface sialoglycoprotein. Among 
many functions it has been shown that SCG2 promotes the differentiation of 
neuroblastoma cells into neurons (Li et al., 2008). Similarly, secretoneurin II, a brain 
peptide derived from endoproteolytic processing of SCG2, can promote the 
outgrowth of immature cerebellar granule cells (Shyu et al., 2008). It has been 
reported that Schizophrenia in humans is associated with upregulation of human 
SCG2 mRNA in dorsolateral prefrontal cortex (Hakak et al., 2001).  
 
Importantly, in a published proteomic study of cerebrospinal fluid, VGF and the 
related SCG2 protein were identified as the two biomarkers most able to discriminate 
between depression and healthy control samples, whereas VGF alone was critical in 
distinguishing schizophrenia from control samples (Huang et al., 2006). Their 
regulation by the NPAS3/SOX developmental cascade suggests a unifying 
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hypothesis: these two secreted biomarkers report a neurogenic pathology associated 
with psychiatric disorders. 
 
GADD45B, another highly up-regulated target by NPAS3, SOX5 and SOX6, plays a 
similar role in adult activity-dependent neurogenesis by stimulating BDNF/FGF 
signalling and promoter demethylation (Ma et al., 2009b). GALR2, encoding a 
galanin receptor, was the only gene to be up-regulated by all 5 transcription factors. 
Galanin and its receptors have established roles in neurogenesis, mood, depression 
and anxiety (Karlsson and Holmes, 2006; Kuteeva et al., 2008; Lu et al., 2008). 
 
The neurofilament heavy polypeptide (NEFH) is  one of the major components of 
neuronal cytoskeleton neurofilaments (Lee and Cleveland, 1996). NEFH was found 
to mediate the interaction between neurofilaments and brain mitochondria (Wagner 
et al., 2003). Absent or diminished NEFH expression has been reported in human 
automic neuronal tumours or central neurocytomas, human prostate cancer, clear-cell 
epithelioid tumor and small lung carcinoma. (Bobos et al., 2006; Mena et al., 2001; 
Schleicher et al., 1997; Segal et al., 1994; You et al., 2005). Variants of NEFH are 
associated with the development of amyotrophic lateral sclerosis, which is a 






4.4.2 Evidence that SOX genes are involved in neurogenesis 
Sox11 was found prominently expressed in the neurogenic area of adult brain where 
it is strictly expressed with Dcx –expressing precursors and immature neurons, but 
not with Sox2-expressing non-committed precursors and immature cells (Haslinger 
et al., 2009). As Npas3 is also found colocalised with Dcx in the adult mouse 
hippocampus and they are both transcriptional regulators, we hypothesise that 
NPAS3 and SOX11 are both involved in the regulation of specific genes at the stage 
of the immature neuron. In particular, it will be important to further characterise the 
roles of NPAS3 and SOX target genes in embryonic and adult neurogenesis- 
processes that seem to correlate with the risk of depression and psychosis 
(Kempermann et al., 2008).  
4.4.3 Npas3 down-regulates SOX11, why do these genes both act as 
down-regulators of several genes? 
A surprising observation was that many genes were down-regulated both by NPAS3 
and by SOX11. This is puzzling because SOX11 is down-regulated by NPAS3 
(Figure 3.4 and Figure 3.5). Although SOX11 and NPAS3 are very powerful 
transcription factors, the number of genes directly regulated by them is very limited. 
It is very possible that a small change in the activity of particular genes causes a 
similar change nearby, which then causes another similar change and so on in liner 
sequence. Thus, these genes may not be directly regulated by NPAS3 and SOX11, 
but may show altered expression due to the interactions with other genes in the 
pathway. 
There is also another possibility that SOX11 is not directly regulated by NPAS3, but 











5 An interaction between NPAS3 and the circadian rhythm 
5.1 Introduction 
NPAS2 (Neuronal PAS domain protein 2) is another member of the bHLH-PAS 
superfamily of transcription factors, which is highly expressed in the CNS. NPAS2 
contains a basic-helix-loop-helix structure motif and PAS domain, like NPAS3. It is 
one of the components of the circadian clock oscillator. The other components 
include the CRY proteins, CLOCK, BMAL1, BMAL2, CSNK1D, CSNK1E, 
TIMELESS and the PER proteins. NPAS2 polypeptides are highly similar in primary 
amino acid sequence to CLOCK and have been shown to behave similarly in 
biochemical and cell based experiments (Hogenesch et al., 1998; McNamara et al., 
2001; Reick et al., 2001; Rutter et al., 2001). In mammals, a heterodimer composed 
of CLOCK and BMAL1 is the positive transcription factor in the negative feedback 
cycle of the regulation of circadian rhythm. This regulation is inhibited in a feedback 
loop by CRY and PER. NPAS2 has also been implicated in the redox-sensitive 
control of gene transcription (Rutter et al., 2002; Rutter et al., 2001).  In particular, 
NPAS2 was shown to up-regulate the expression of one unit of lactate 
dehydrogenase (LDH), an enzyme that inter-converts lactate and pyruvate generated 
by glycolysis (Rutter et al., 2001). NPAS2 was shown to be associated with seasonal 
affective disorder (SAD), which describes depression made worse by the absence of 
sunlight during winter months (Partonen et al., 2007). 
 
NPAS3 has similar function domains to NPAS2, and we can speculate that NPAS3 
might also participate in circadian signalling. Furthermore, NPAS3 (like all basic 
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helix-loop-helix transcription factors) functions as a heterodimer with partners such 
as the BMAL (ARNTL) proteins. BMAL1 is also involved in circadian time-keeping. 
Additionally, altered circadian rhythmicity, producing symptoms of sleep 
disturbance or metabolic dysfunction, is found in individuals diagnosed with 
depression and other mood disorders, although it is probably unrelated to the speed 
of ‘cycling’ between the manic and depressed states (Kato, 2007; Lamont et al., 
2007). Based on this background information, the question was addressed whether 
constitutive NPAS3 overexpression actively alters circadian rhythm in these cells or 
is, alternatively, passively influenced by it. 
 
5.2 Aims of this study 
To test the hypothesis that NPAS3 is involved in the circadian rhythm, Illumina 
microarray analysis was carried out to investigate the gene expression changes in 





5.3.1 Confirmation of in vitro circadian induction by serum shock 
approach 
In order to induce the circadian rhythmicity in an in vitro system, HEK293 cells were 
treated using a serum shock approach. HEK293 cells were cultured close to 
confluence and at the zero hour time-point, the cells were shifted into a serum-rich 
medium to induce circadian cycling (Balsalobre et al., 1998; Huang et al., 2009). At 
+2 hours, cells were washed with DMEM and then incubated with the same for the 
remaining period of the experiment. Cells were collected at different time points (0hr, 
4hr, 8hr, 12hr, 16hr, 20hr, 24hr…….72hr). Expression of period (PER) regulator 
genes was analysed at different time points over 72hrs using RT-PCR and agarose 
gel electrophoresis (Fig 5.1). DNA bands were scaned and intensity values were 
normalised to control genes. PER1, PER2 and PER3 show expression changes with a 
18-28 h cycle. Per1 and Per2 are out of phase with each other as previously described. 








Figure 5.1 RT-PCR analysis of a serum shock induces circadian gene expression in HEK293 
cells. 
HEK293 cells were grown close to confluence and shifted to a serum-rich medium, as 
described in the methods. The levels of the cDNA indicated at the left side of the figures 
were determined at different at different times (top of the figure) after serum shock. 18sRNA 
was used as a reference gene which indicated the total cDNA of different samples.  
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5.3.2 NPAS3-specific changes in gene expression in HEK293 cells after 
circadian induction 
The purpose of this experiment was to see the effect of NPAS3 on gene expression at 
+12 and +24 hours after circadian induction in HEK293 cells using Illumina 
microarray. (Appendix Table S3-4) The fragments of FLNPAS3 and ∆NPAS3 open 
reading frames were transferred into a similar TET-inducible expression plasmid and 
transfected into HEK293 [T-REx-293] cells (Invitrogen). At the zero hour time-point, 
cells were shifted into a serum-rich medium plus tetracycline in order to induce both 
circadian cycling and NPAS3 overexpression (Balsalobre et al., 1998; Huang et al., 
2009). Parental HEK293 [T-REx-293] cells without NPAS3 constructs were treated 
in the same way to act as negative controls. Ideally, unactivated (tetracycline) 
FLNPAS3/∆NPAS3 cells would have bee used as controls but these cell lines 
showed a low level of leaky transcription in the absence of tetracycline. At +2 hours, 
cells were washed with DMEM and then incubated with the same plus tetracycline 
for the remaining period of the experiment. Cell samples from the three experimental 
groups were collected at +12hrs and +24hrs respectively. For all circadian cell 
culture experiments with FLNPAS3/∆NPAS3/parental negative control cell lines, 
duplicate biological samples were assessed. Microarray probes synthesised from 
RNA extraction products were quantified using an Agilent Bioanalyzer to ensure 
high quality probes of equal quantity between experiments. Sentrix® HumanRef-8 
v2 chips (capable of examining expression of over 24,500 gene transcripts) were 




As a first test of the data, changes in gene expression in control cells were studied 
(Appendix table S1). Many genes were showed higher expression at +24 hrs 
compared to +12 hrs, including FOS, FOSB, EGR1, EGR2, EGR3 and PER2, all 
involved in transducing light entrainment during the dark phase of the circadian 
rhythm. A search for significant gene functions in the top 100 circadian genes with 
lower expression at +24 hrs compared to +12 hrs identified a group of 10 genes 
involved in the regulation of cell cycle progression (GO:0007049, p=1.31546 ×10-6). 
These were FBXO5, SPC25, CDKN1B, RAD21, CKAP2, MAD2L1, GAS1, ZWILCH, 
CDC2 and RBBP4. Cell cycle genes were also reported to be deregulated in a cell 















5.3.3 The regulatory activities of FL/∆NPAS3 have been changed by 
circadian environment  
In this culture system FL/∆NPAS3 activity was strongly modified by circadian 
cycling in two principal ways. Firstly, NPAS3 activity on target gene expression was 
almost universally inhibitory at +12 hours. Secondly, NPAS3 down-regulated target 
genes differed considerably between +12 hours and +24 hours (Appendix table S3-4). 
The detail of modification by circadian cycling on FL/∆NPAS3 activity will be 
further investigated in the later part of this chapter. 
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5.3.4 Many standard culture down-regulated genes were also down-
regulated in the circadian experiments: a link to hypoxia signalling 
Only seven genes up-regulated in the standard culture conditions NPAS3 over-
expression study were also up-regulated in the circadian experiment: CDKN1A, 
CENPF, GALR2, HIST1H1C, HIST1H2BD, PCDH7, and SPHK2. By contrast, a 
larger overlap existed between standard and circadian down-regulated genes. While 
the majority of the overlapping genes were specific to +12 hours, 21 were down-
regulated by FLNPAS3 at both time-points. The over-represented ontologies were 
identified by a GeneCodis2 search. 4 genes (PLOD2, ALDOC, BNIP3, DDIT4) were 
found to be associated with a response to hypoxia (GO:0001666) with a significant 
corrected hypergeometric p-value of 4.86 X 10-6. Further manual annotation showed 
that all of the 20 genes, except HOXA13 have published evidence for up-regulation 








































































































































































































5.3.5 ∆NPAS3 and FLNPAS3 differences exposed by circadian 
stimulation 
In order to compare the difference of FLNPAS3 and ∆NPAS3 in the circadian 
environment, the gene regulation of these two factors was analysed by scatter plots 
(Figure 5.3). In contrast to standard culturing conditions, the circadian microarray 
exposed significant functional differences between ∆NPAS3 and FLNPAS3 at +12 
hours after induction of circadian rhythm (Appendix table S2). This was generally 







Figure 5.3 Normalised and log-transformed expression data for over 24,000 probes (18,000 
genes). The diagonal represents equal expression in both conditions. Genes (shown in red) 
outside of the two parallel diagonal lines show at least 1.5-fold difference between the two 
conditions. Regulatory differences between FLNPAS3 and ∆NPAS3 at the +12 (a) and +24 




5.3.6 An interaction between NPAS3 activity and the circadian rhythm 
To further explore the relationship between circadian time-point, FL/∆NPAS3 
activity on target gene regulation, we visualised microarray data using ternary plots. 
Briefly, a set of functional related genes were chosen for different comparision. Then, 
the expression values of these genes were looked up in different cell samples in our 
circadian microarray data file. Finally, the gene expression values were input into 
ProSim, to generate the ternary plot results. Ternary plots indicate the relative 
influence of each of the three experimental conditions - FLNPAS3, ∆NPAS3 and 
control – on gene expression. Any deviation from the centre of the plot indicates that 
either one or two conditions is/are disproportionally influencing expression. Gene 















As a first test, we input 109 randomly selected genes into ternary plots to look for 
biases in the data (Figure 5.4 a). The randomly selected genes show no deviation 
from the centre (Figure 5.4 a) discounting systemic microarray biases, and give an 
example of a group of genes which are not affected by the overexpression of 
FLNPAS3/∆NPAS3.   
 
Figure 5.4 a Ternary plot illustrates the relative effects of FLNPAS3 over-
expression, ∆NPAS3 over-expression and control conditions on target gene 
expression. The relative expression levels of 109 randomly selected genes in the 
three conditions are plotted for +12hrs (green) and +24hrs (red) time-points. The 
absence of substantial deviation from the centre indicates the overall similarity 
between the conditions. 
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The next set of genes analysed were two sets of control cell line (circadian induced 
HEK293 cells without overexpression of FLNPAS3/∆NPAS3) genes (200 genes) 
appearing to show circadian regulation: 100 up-regulated genes between +12 and 
+24 hrs (circles) and 100 down-regulated genes between +12 and +24 hrs (squares). 
These were plotted to test the influence of FLNPAS3 or ∆NPAS3 over-expression on 
circadian processes. (Figure 5.4 b). This result suggests that at +24hr time point (red 
squares and circles), FL/∆NPAS3 effects on gene expression are small and 
equivalent (along the vertical ‘control’ axis distribution), whereas a pronounced 
effect was seen at +12 hours (green squares and circles). The substantially deviating 
group (green squares) indicates that ∆NPAS3 strongly inhibits (movement away 
from the ∆NPAS3 triangle vertex) the expression of the group of genes at +12 hrs 







Figure 5.4 b Ternary plots illustrate the relative effects of FLNPAS3 over-
expression, ∆NPAS3 over-expression and control conditions on target gene 
expression. Two sets of control cell line genes appearing to show circadian 
regulation: 100 up-regulated genes between +12 and +24 hrs (circles) and 100 down-
regulated genes between +12 and +24 hrs (squares). Again, +12hr expression is 
indicated by green and +24hr by red. The substantially deviating group (green 
squares) indicates that ∆NPAS3 strongly inhibits (movement away from the 
∆NPAS3 triangle vertex) the expression of the group of genes at +12 hrs that will be 
further down-regulated by +24hrs. Both FLNPAS3 and ∆NPAS3 alter the expression 















The third set of genes studied were a panel of 139 published genes known to be up-
regulated in response to hypoxia-stimulated HIF1A (Benita et al., 2009; Chi et al., 
2006; Greijer et al., 2005; Mense et al., 2006) (Figure 5.4 c), Many hypoxia pathway 
genes were inhibited equally by ∆NPAS3 and FLNPAS3, particularly at +12hrs 




Figure 5.4 c Ternary plots illustrate the relative effects of FLNPAS3 over-expression, 
∆NPAS3 over-expression and control conditions on target gene expression. Both 
FLNPAS3 and ∆NPAS3 inhibit the expression of many hypoxia genes at +12 (green) 





Fourthly, 15 microarray probes corresponding to 14 NPAS3-regulated glycolysis 
genes were also analysed by ternary plots, these genes include PFKFB4, PCK2, 
PKM2, ALDOA, ALDOC, ENO2, PKM2, GAPDH, PFKP, HK2, PFKFB3, PGK1, 
PKM2, and PGM1. (Figure 5.4 d). The set of glycolysis genes showed deviations 
from the centre consistent with both NPAS3 forms inhibiting expression at +24hrs, 




Figure 5.4 d Ternary plots illustrate the relative effects of FLNPAS3 over-
expression, ∆NPAS3 over-expression and control conditions on target gene 
expression. 15 glycolysis genes are inhibited by FLNPAS3 and ∆NPAS3 although 
FLNPAS3 activity is much stronger than ∆NPAS3 at +12 hrs (green) and PCK2 is 




Microarray data arranged by chromosomal gene position revealed NPAS3 regulation 
of clustered histone target genes (chapter3). In the fifth ternary plot histone genes on 
chromosome 6 regulated by SOX11 (circles) and on  chromosome 1 regulated by 
NPAS3 (squares) were assessed .This result shows a striking inhibition of 
chromosome 1 histone expression by FLNPAS3 and ∆NPAS3 at +12hrs only (Figure 
5.4 e).  Furthermore, the inhibition capabilities of FLNPAS3 and ∆NPAS3 are equal.  
 
 
Figure 5.4 e Ternary plots illustrate the relative effects of FLNPAS3 over-expression, 
∆NPAS3 over-expression and control conditions on target gene expression. 
Chromosome 1 histones (squares) are substantially inhibited by both FLNPAS3 and 






Finally, there were a large number of small (RPS) and large (RPL) ribosomal protein 
genes regulated in the microarray datasets. Ribosomal proteins (small subunits: 
squares, large subunits: circles) were input into ternary plot. This result provides 
evidence for FL/∆NPAS3 inhibitory activity at +12hrs and some stimulatory activity 
at +24hrs (Figure 5.4 f)  
 
Figure 5.4 f Ternary plots illustrate the relative effects of FLNPAS3 over-expression, 
∆NPAS3 over-expression and control conditions on target gene expression. 
Ribosomal proteins (small subunits: squares, large subunits: circles) show up-






Although not presented here, a previous RT-PCR experiment did not show circadian 
changes in the expression of the NPAS3 gene itself suggesting that the gene is not a 
central part of the circadian control pathway. But the microarray results show that the 
regulatory activity of FLNPAS3 was strongly modified by circadian cycling. These 
might be due to the fact that many co-functioning partners of NPAS3 (such as 
BMAL) are bHLH family member and controlled by circadian rhythms. 
 
Although the second PAS domain and the putative transactivation domain are absent 
in ∆NPAS3 the microarray data show that the regulatory actions of FLNPAS3 and 
∆NPAS3, as in the standard culture conditions, are largely similar at 24hrs time point 
(Figure 5.3 b and Figure 5.4 b-e red). As ∆NPAS3 has a bHLH domain, it still keeps 
the ability to form heterodimerized complex. 
 
In our microarray results, the regulatory profiles of these two proteins are different at 
12 hrs. At 12 hr, the dominant function of NPAS3 is due to the 
transactivation/transdepression domain, and the actions of bHLH domain and PAS-A 
are limited, therefore, the transcriptional regulatory activities of FLNPAS3 and 
∆NPAS3 are significantly different. While at 24 hrs, it is possible that the bHLH 
domain, which has the property to form a heterodimerized complex, has the 
dominant role in the transcriptional regulatory of NPAS3. Because both ∆NPAS3 
and NPAS3 keep the bHLH domain, there is no big difference between NPAS3 and 
the truncated form, ∆NPAS3. 
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This hypothesis also explains why NPAS3 activity is sensitive to circadian time-
point. FL/∆NPAS3 activity was strongly modified by circadian cycling in two main 
ways. This possibly due to the expression levels of several potential NPAS3 partners 
are affected by circadian rhythm.  
 
Based on the ternary plot results, there are several interesting findings:  
Firstly, the circadian microarray result revealed a direct modulatory interaction 
between NPAS3 activity and circadian rhythmicity. This interaction includes: 1), 
∆NPAS3, but not FLNPAS3, inhibited the expression levels of a set of potential 
circadian genes which showed a decrease between +12 and +24 hours in the control 
group (Figure 5.3.b). 2), both FLNPAS3 and ∆NPAS3 inhibited the expression of 
multiple target gene groups such as glycolysis (Figure 5.3.d), hypoxia response genes 
(Figure 5.3.c) and chromosome 1 histone cluster (Figure 5.3.e).  
 
Secondly, in both instances these effects were either exclusive to, or amplified at the 
+12 hour time-point. It is intrinsically difficult to separate cause from effect from the 
limited time-points studied here. However, only the +12hr ∆NPAS3 effect suggests a 
direct modulation of circadian master regulator gene activity resulting in circadian 
phase (wavelength shift). ∆NPAS3 is generated by cleavage at an XhoI site which 
removes the second PAS domain and the putative transactivation domain. So it only 
has the properties to heterodimerize with other partners and bind to specific DNA 
sequence. Therefore, one hypothesis to explain this observation could be that the 
truncation of NPAS3 overcomes restrictions on the normal range of transcriptional 
binding partners– permitting abnormal interaction with circadian bHLH transcription 
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factors active at +12hrs. It can be appreciated that gene mutations with similar effects 
to the truncation might also upset circadian rhythms.  
 
Thirdly, our ternary plot analysis on hypoxia genes revealed that both FLNPAS3 and 
∆NPAS3 can inhibit many hypoxia genes at +12hr and +24hr (Figure 5.4.c). The 
underlying mechanism of this phenomenon might due to ‘binding partner choice’. In 
fact, after NPAS1, SIM1 and SIM2, HIF1A possesses the most homologous bHLH 
domain to NPAS3. Because the inhibitory capabilities of FLNPAS3 and ∆NPAS3 
are different at +12hrs and +24hrs in our cell models, I further propose that this 
NPAS3/hypoxia pathway functions is sensitive to circadian state. Reports that 
hypoxia can affect the amplitude of the circadian output also strengthen the argument 
that HIF1A participates in cross-talk with circadian pacemaker factors (Bosco et al., 
2003; Ghorbel et al., 2003; Mortola, 2007; Vargas et al., 2001). As NPAS3 did not 
show a circadian expression pattern in our cell models (both in the normal PCR 
result and in the microarray result), I do not hypothesise that NPAS3 has the capacity 
to sense its environment directly, although it is highly related to transcription factors 
















6 SOX11 target genes: implications for neurogenesis and 
neuropsychiatric illness 
6.1 Introduction 
The proliferation of progenitor cells and their differentiation into functional neurons 
are critical processes during developmental and adult neurogenesis. As growing 
evidence suggests that neurogenesis deficits play a role in neurological and 
psychiatric disorders, such as schizophrenia and bipolar disorder (more information 
is available in 1.3.1), it is important to understand the underlying molecular 
mechanisms. SOX family members play an important role in adult neurogenesis and 
SOX11 is one of the negatively regulated genes of NPAS3. This chapter describes 
experiments to define the regulatory profile of SOX11.  
 
Sox C members, including Sox4, Sox11 and Sox12, possibly play a key role during 
the regulation of later aspects of neurogenesis. They are mainly expressed in 
neuronal cells which have been committed to neuronal differentiation (Cheung et al., 
2000). Sox4 and Sox11 regulate the establishment of pan-neuronal protein 
expression by inducing precocious expression of neuronal markers in self-renewing 
precursors. SOX11 is the most powerful transcription factor among these three 
factors (Bergsland et al., 2006). SOX11 is critical during the later stages of 
neurogenesis. However, the regulatory targets and downstream pathways at the 
molecular level are yet to be fully demonstrated.  
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Sox11 null mice die during the neonatal period due to malformations of heart and 
internal organs including dysgenesis of the anterior eye segment, hypoplastic lungs, 
undermineralized bones and lack of a spleen (Bergsland et al., 2006).  SoxC triple-
deleted mouse embryos die at midgestation and are tiny. Although the patterning and 
lineage specification are normal, there is massive apoptotic loss of neural and 
mesenchymal progenitor cells (Bhattaram et al., 2010). 
 
The ‘neurodevelopmental’ hypothesis of neuropsychiatric disorders such as 
schizophrenia, bipolar disorder and autism suggests that deficits in the proliferation, 
differentiation and connectivity of neurons during the formation of the brain might 
contribute towards increased risk of illness. Supporting a role for SOX11 in this 
context is a case report recently describing a 7-year-old patient with autism, 
moderate mental retardation, secondary microcephaly, agenesis of right opti nerve, 












6.2 Aims of this study 
Here we describe the over-expression of SOX11 in the HEK293 cell line followed by 
microarray analysis to deduce the set of target genes and their ontologies. Briefly, 
HEK293 cells were transiently transfected by pDEST40-SOX11 or control plasmid 
(pDEST40) using lipofectamineTM 2000 transfection kit (Invitrogen). After 4-6 hours, 
the transfection medium was replaced with the standard culture medium for 24 hours. 
Microarray probes synthesised from RNA extraction products was quantified using 
an Agilent Bioanalyzer to ensure high quality probes of equal quantity between 
experiments. Sentrix® HumanRef-8 v2 chips (capable of examining expression of 
over 24,500 gene transcripts) were used to detect gene expression profiles.  
 
In addition, to investigate the distribution of SOX11 in the adult mouse hippocampus, 
immunofluorescence was used to localise SOX11 and several of its targets within the 




6.3.1 Transient overexpression of SOX11 in HEK293 cells results in 
specific gene expression changes as assessed by microarray 
 
Illumina microarray analysis was carried out to investigate the gene expression 
changes in HEK293 cells after over-expressing SOX11. For all standard cell culture 
experiments with SOX11/ parental negative control cell lines, triplicate biological 
samples were assessed. BRB analysis software was used to analyse the expression of 
the 22,177 well annotated RefSeq transcripts present in each array. Unsupervised 
hierarchical clustering of gene expression profiles using centred correlation and 
average linkage revealed that human SOX11 and control transfection samples have 
distinct profiles (Figure 6.1). This was an indication of both the consistency of the 













Figure 6.1 Dendrogram of SOX11 transfected and control HEK293 cell samples. 
Hierarchical clustering based on microarray data from each sample reveals two 
distinct clusters corresponding to SOX11 transfected (H1-3AVG) and control cells 
(L1-3AVG), using centered correlation and average linkage. Thus SOX11 




6.3.2 Identification and validation of SOX11 regulated genes 
This section of the thesis was a collaboration with Rob Kitchen, a PhD student 
working in the bioinformatics department of University of Edinburgh.   
 
Limma (designed by Rob Kitchen) and BRB-Array Tools approaches used in the 
microarray data analysis generated highly similar results at the levels of rank, fold-
change and P-value. 932 genes were significant by SAM analysis. The estimated 
false discovery rate among the 932 significant genes was set at 0.01. Supervised 
analyses were next performed to identify gene expression differences between 
human SOX11 transfected and untransfected HEK293 cells, at a significance level of 
P<0.01. 251 genes with expression levels altered by at least 1.5-fold were selected 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6.3.3 Confirmation of SOX11 microarray findings at the transcriptional 
and protein levels and in a second cell line 
In order to validate our microarray findings, QPCR analysis was carried out on 
several selected genes using the same RNA used in our microarray experiment. The 
QPCR reactions were performed in triplicate and the double delta method was used 
to calculate the gene expression level. 
 
A panel of eight representative genes (NDP, NEDD9, HIST1H2BE, HIST1H2AE, 
SEMA3, BAG1, TUBB3, FILIP1, CYP39A, SCG2, CD24) with a robust fold change 
in microarray data (Figure 6.2 A) were chosen for validation using QPCR on the 
same RNA as used in the microarray experiment. Gene 18sRNA was used to 
normalise data from SOX11 over-expression and control samples and values are 
expressed as fold-change in gene expression in comparison to the control samples 
(HEK293 cells tansiently transfected with pDEST40 plasmid). Results of this 
analysis are shown in (Figure 6.2B).  
 
To determine if SOX11 regulates similar targets in an alternative cell line, SH-SY5Y 
cells were transiently transfected with the SOX11-expressing construct. Western blot 
analysis was carried out on two proteins, SCG2 and TUBB3, which displayed up-
regulation in the microarray analysis. Both showed clear up-regulation of expression 
in comparison to ‘empty vector’ or ‘no DNA’ control transfections when normalised 







Figure 6.2. QPCR and Western blotting verify microarray findings. 
Expression of CD24, CYP39A1, FILIP1, HIST14E, HIST1H2BD, NDP, SCG2, 
SEMA3B and TUBB3 determined by microarray (A) and QPCR (B). (A) Microarray 
signal intensities are expressed as an average of cDNA triplicates from HEK293 cells 
treated lipofactemine (as control) and cDNA triplicates from SOX11-overexpressed 
HEK293 cells. (B) fold-change values in the QPCR figure were calculated from 
triplicated analysis of the same RNA used in the microarray assays. (C) SH-SY5Y 
cells were transiently transfected with plasmids pDEST40-SOX11 or empty 
pDEST40, or a Lipofectamine alone control and cultured for 48h. YWHAZ was used 
as a reference protein. The protein levels of TUBB3 and SCG2 were significantly up-
regulated in the cell that over-expressed SOX11 protein. 
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6.3.4 Kinetics of SOX11 activity: time-course Q-PCR  
To assess the kinetics of up-regulation of selected genes from the microarray, a time-
course QPCR experiment was carried out. This would provide information on how 
quickly SOX11 acts on target gene promoters (or perhaps if some of the targets were 
indirectly/secondarily regulated). Transient transfection of SOX11 was followed by 
harvesting of RNA at 0h, 3h, 6h, 12h, 24h and 48h (the time-point at which 
microarray analysis was performed). We compared the temporal changes in 
expression of several upregulated genes FILIP1, CYP39A1, SEMA3B, SCG2, GSTA2, 
TUBB3, relative to control genes (Figure 6.3). These genes were chosen based on the 
following criteria: 1) these genes were identified as candidate molecules participating 
in the process of early neuron development, and 2) these genes can show fairly 
robust changes in our microarray list (fold change more than 2). 
 
Comparing the fold changes of these genes revealed a dynamic set of expression 
profiles that fell into 3 sequentially and transiently upregulated groups: 1) CYP39A1 
and TUBB3 were increased at 6h, reached their peaks by 24h, 2) GSTA2, SCG2 and 
SEMA3B were up-regulated by 12h, 3) FILIP1 was up-regulated and reached its peak 
at 24h. This result suggests that regulation mechanisms by SOX11 on these genes 









Figure 6.3 Timecourse QPCR of SOX11 transiently transfected HEK293 cells. RNA 
obtained at different time point (from 0h-48h) after HEK293 cells were transiently 
transfected with SOX11. Each time point represents fold change (mean +/- s.d. of 
assay triplicates) in comparison to gene expression in HEK293 cells transfected by 




6.3.5 IPA analysis of SOX11 microarray data 
Ingenuity Pathway Analysis (IPA) was used to identify canonical networks and 
biological functions/ gene ontology over-represented within the list of 251 SOX11 
up-regulated genes with a fold change more than 1.5. IPA functional analysis 
produces three primary categories of output: molecular and cellular functions; 
physiological system development and functions; diseases and disorders. Several 
neurogenesis relevant functions and neurological diseases were over-represented in 
the dataset (Table 6.2) including cell cycle, cell death, cell signalling, cell-to-cell 
signalling and interaction, cell growth and proliferation, gene expression (regulation), 
and lipid metabolism. 18 SOX11 up-regulated genes were also shown to be involved 
in nervous system development and function with roles in chemotaxis, growth cone 
collapse, and familial encephalopathy with neuroserpin inclusion bodies, 
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6.3.6 Several neurogenesis and psychiatric illness candidate genes are 
regulated by SOX11  
SOX11 is enriched in developing neurons, oligodendrocytes and astrocytes in human 
brain (Cahoy et al., 2008). Our hypothesis is that it is involved in the processes 
involved in CNS development and disease was supported by the microarray data as 
they revealed several genes with known involvement in adult and developmental 
neurogenesis as well as genes with established links to neuropsychiatric illness. 
These genes include: 
 
1) Glypican-2, a heparan sulphate proteoglycan. It is significantly up-regulated by 
SOX11 in our microarray list (Fold change:4.225). It was reported associated with 
developing nervous system in axons growth cones (Kurosawa et al., 2001). In our 
study, Gpc2 is found expressed in the inner side of subgranular zone of adult mouse 
hippocampus, with very low expression in other parts of the brain. This expression 
pattern is quite similar to those markers for early axon growth from new neurons. 
These findings suggest that SOX11 maybe involved in the process of axon growth 
through its transcriptional activity on other genes. 
 
2) Scg2 (Secretogranin II/Chromogranin-C) is a cell surface sialoglycoprotein. 
Among many functions it has been shown that SCG2 promotes the differentiation of 
neuoblastoma cells into neurons. It was reported that Schizophrenia in humans is 
associated with upregulation of human SCG2 mRNA in dorsolateral prefrontal 
cortex (Hakak et al., 2001). And also Secretoneurin II, a peptide derived by 
endoproteolytic processing from SCG2 in brain, can promote the outgrowth of 
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immature cerebellar granule cells (Shyu et al., 2008). Also SCG2 is a marker for 
schizophrenia in cerebrospinal fluid (Bartolomucci et al., 2010). 
 
3) Our microarray results show that FILIP1 is the top unregulated gene by SOX11. It 
interacts with Filamin A and plays a regulatory role in neocortical cell migration 
from ventricular zone (Nagano et al., 2002).  
 
4) NDP is another SOX11 up-regulated gene with robust expression change. NDP is 
a secreted protein with a cystein-knot motif that activates the Wnt/beta-catenin 
pathway. It forms disulfide-linked oligomers in the extracellular matrix. NDP was 
isolated as a candidate gene for the Norrie Disease gene which is associated with 
congenital blindness sometimes associated with mental retardation and hearing loss 
(Chen et al., 1993). The characterization of deletions of this gene in Norrie disease 
and function analysis was carried out by Chen et al (Chen et al., 1993). NDP protein 
acts as an alternative to wnt ligand on the FZD4 receptor and has been implicated in 
angiogenesis. 
 
5) TUBB3 is on the list of significantly up-regulated genes and also shows 
significant upregulation in SOX11-overexpressed SHSY5Y cells (Figure 6.2, 
western result). TUBB3 is abundant in the brain and widely regarded as a marker for 
differentiating neurons (Katsetos et al., 2003). Tubb3 has three potential binding sites 
for Sox4 and Sox11, which are located upstream of the Tubb3 transcriptional start 
site and has therefore been previously suggested as a target gene (Bergsland et al., 
2006; van Beest et al., 2000). A recent paper highlights the role of TUBB3 in axon 
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guidance in a human CNS syndrome with behavioural phenotypes (Tischfield et al., ; 
Tischfield and Engle, 2010). 
 
6) CD24 is in the top 10 of the genes up-regulated by SOX11. It is a small, 
glycosylphosphatidylinositol-anchored membrane protein, plays a role in B-cell 
development and neurogenesis (Calaora et al., 1996; Poncet et al., 1996). In adult 
mouse CNS, the expression of Cd24 is restricted to differentiating neurons in the 
subventricular zone and dentate gyrus and is a frequently used biomarker for 
neurogenesis in the brain (Belvindrah et al., 2002; Nieoullon et al., 2005). 
 
7) ST7, also known as RAY1 or FAM4A1, is disrupted by a translocation breakpoint 
in a patient diagnosed with autism (Vincent et al., 2000; Vincent et al., 2002) 
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6.3.7 Histone and zinc finger genes and chromosomal domain 
regulation by SOX11 
Thirteen histone genes were up-regulated by overexpression of SOX11. Closer 
inspection showed that many were present within a cluster on chromosome 6. We 
therefore reassessed the microarray fold-change data in relation to gene 
chromosomal coordinates and observed apparent clustering of up-regulated genes in 
several areas, with chromosomes 6p22.2 and 19q13.43 showing the most robust 
findings (Figure 6.4 a, b and c). This suggested that the transcriptional effects of 
SOX11 might be indirect in some circumstances: mediated through the alteration of 
regional chromatin state rather than by direct promoter effects. Some circumstantial 
evidence for this is provided by the bell-shaped distribution of SOX11 histone gene 
up-regulation in the chromosome 6 cluster suggesting a spreading and attenuating 
influence from a central regulatory point. The subsets of genes that are present within 
these two clusters are listed in Table 6.3. Most of them are members of the histone or 
zinc finger families. The chromosome 6 region is the site of a very promising genetic 
finding relating to increased risk of schizophrenia. A genome-wide association study 
found multiple single nucleotide polymorphism (SNP) associations. Four of the most 
significant markers, SNPs rs6913660, rs13219354, rs6932590, and rs13211507, are 
found within our SOX11-regulated cluster (Purcell et al., 2009; Stefansson et al., 
2009). This association has been previously interpreted to indicate a role for the 
nearby HLA genes in disease risk (Figure 6.4b). However, we now suggest that 







Figure 6.4 Clustering of SOX11-regulated genes. 
Average fold-changes in a sliding window of 30 genes along the length of all 
chromosomes were calculated and plotted (top). Strong peaks indicating clustered 
up-regulation of genes were observed on chromosomes 6 and 19 (below). In the 
lower figures, red bars indicate statistically significant gene up-regulation 
(predominantly histone/zinc finger genes) as determined in the SAM analysis. The 
horizontal black bar indicates the approximate location of the HLA gene cluster  
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Table 6.3 Significantly (SAM) regulated genes, shown in order, that are found within 
clusters on chromosomes 6 and 19. The two genes highlighted in bold show down-
regulation, the rest are up-regulated. Histones and zinc finger proteins comprise the 
majority of the list. 
Cluster Gene symbol Acc. No. Fold-change 
Chr.6 MAK NM_005906 1.73 
Chr.6 NEDD9 NM_182966 1.82 
    
Chr.6 HIST1H4B NM_003544 1.41 
Chr.6 HIST1H1C NM_005319 2.27 
Chr.6 HIST1H2AC NM_003512 1.84 
Chr.6 HIST1H2BD NM_138720 3.69 
Chr.6 HIST1H2BE NM_003523 1.28 
Chr.6 HIST1H4E NM_003545 2.53 
Chr.6 HIST1H2BG NM_003518 2.21 
Chr.6 HIST1H2AE NM_021052 1.75 
Chr.6 HIST1H3F NM_021018 1.25 
Chr.6 HIST1H4H NM_003543 5.21 
Chr.6 BTN2A2 NM_181531 1.53 
Chr.6 BTN3A1 NM_007048 1.16 
Chr.6 ZNF184 NM_007149 2.23 
Chr.6 HIST1H3H NM_003536 1.36 
Chr.6 HIST1H4K NM_003541 1.54 
Chr.6 HIST1H2BN NM_003520 1.60 
Chr.6 HIST1H2AM NM_003514 1.48 
Chr.6 ZNF435 NM_025231 2.47 
Chr.6 ZNF193 NM_006299 2.32 
Chr.6 ZNF187 NM_001023560 1.62 
Chr.6 ZNF323 NM_030899 1.53 
Chr.6 ZNF96 NM_014724 1.27 
Chr.6 UBD NM_006398 1.28 
Chr.19 ZNF71 NM_021216 1.39 
Chr.19 ZNF548 NM_152909 2.05 
Chr.19 ZNF17 NM_006959 1.60 
Chr.19 MGC4728 NM_198542 1.36 
Chr.19 ZIK1 NM_001010879 1.99 
Chr.19 ZNF211 NM_006385 1.76 
Chr.19 ZNF671 NM_024833 1.65 
Chr.19 ZNF256 NM_005773 1.66 
Chr.19 C19orf18 NM_152474 1.58 
Chr.19 ZNF606 NM_025027 1.41 
Chr.6 SIRT5 NM_012241 0.72 
 Chr.6 PRSS16 NM_005865 0.67 
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6.3.8  The expression patterns of SOX11 regulated genes in 
dentate gyrus of the hippocampus 
The expression pattern of Sox11 in the adult mouse hippocampus, the site of 
neurogenesis that continues into adulthood, was investigated using 
immunofluorescence microscopy. Sections from frozen mouse brain were cut using a 
thermo cryostat. The following antibody solutions and dilutions were used: 1/500 
Sox11 rabbit anti mouse, 1/400 Gpc2 goat anti mouse (Santa Cruz Biotechnology). 
The sections were mounted on slides with Prolong anti-fade reagent with 4’6-
diamidino-2-phenylindole (DAPI). Sox11 was found to be expressed in many brain 
regions including the whole dentate gyrus, in accordance with the literature. The 
distribution of several Sox11-regulated genes was examined. Gpc2, a gene up-
regulated by SOX11 upregulated gene was localised to the inner sub-granular zone 
of dentate gyrus, where neurogenesis occurs, and had much lower expression in other 
regions of dentate gyrus (Figure 6.5). 
 
 As SOX11 is down regulated by NPAS3 in the microarray data set, colocalization 
between these two proteins in hippocampus were looked for. However, no overlap of 
expression was found in these experiments. (NPAS3 expression pattern in mouse 













































































































































































































































6.4 Discussion  
A cell line-based over-expression study coupled with microarray analysis was carried 
out to characterise the set of genes regulated by SOX11. Evidence suggests that a 
number of SOX11 targets may play a role in the maturation and differentiation of 
neurons as predicted by previous studies.  
 
Sox11 is expressed in the subventricular zone of lateral ventricles and the 
subgranular zone of the dentate gyrus, But Sox11 is strictly localized in Dcx-
expressing neuronal precursors and immature neurons, but not Sox2-expressing cells. 
(Haslinger et al., 2009), Doublecortin (Dcx) is a neurogenesis marker which is 
expressed in newly formed neurons between the timing of their birth and final 
maturation (Brown et al., 2003). This suggests that Sox11 is involved in the 
transcriptional regulation of the specific stage of converting immature neurons into 
final maturation in adult neurogenesis. Although Sox11 does not show colocalization 
with Npas3 in the adult mouse hippocampus, they are both expressed in Dcx-positive 
cells. This suggests that they might have the same temporal and spatial roles in the 
process of adult neurogenesis. 
 
In the analysis of relative fold change in gene expression for different time points, 
several genes responsible for adult and developmental neurogenesis and psychiatric 
disease are differentially expressed by more than 2 fold after over-expression of 
SOX11. The fold changes of several genes, like CYP39A1, TUBB3, and FILIP, are 
increased before 24h, but significantly decrease after 48h.  These results are 
consistent with the possibility that SOX11 might be a part of a special transcriptional 
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regulatory network. Other factors, which depress gene expression, may also be 
activated by the overexpression of SOX1 and together with SOX11 might function as 
a network to control the expression of pivotal genes in different stage of 
neurogenesis.  
 
SOX11 may be regulated by several different mechanisms. These include binding to 
the promoter region directly or through the alteration of local chromatin states 
(Pevny and Lovell-Badge, 1997). These hypotheses are consistent with the finding 
that clusters of genes are regulated by SOX11. At least two clusters of SOX11 targets 
exist, located on chromosomes 6 and 19. And it might be the case that gene 
duplication events in these clusters have produced multiple SOX11-regulated genes. 
This could explain the activation of that SOX11 target genes at different time points. 
 
 The presence of non-histone/zinc finger genes in Table 6.3 suggests that SOX11 
exerts its control over the region through indirect means. It has been previously 
suggested that SOX genes can act by altering chromatin conformation (Wilson and 
Koopman, 2002). This may be compatible with a regulatory model whereby all genes 
within a given ‘loop’ of chromosomal DNA are affected by the local chromatin state 
and its control. The zinc finger genes are often transcription factors themselves while 
the histone genes regulate chromatin state; together these targets may be responsible 
for a co-ordinated programme of genome regulation promoting neuronal fate 
commitment and neuronal gene expression.  
 
 208
Recent genome-wide association studies in schizophrenia have identified the 
strongest susceptibility signal over the chromosome 6 cluster (Purcell et al., 2009; 
Shi et al., 2009; Stefansson et al., 2009). The genes on chromosome 6 involved in 
schizophrenia are not yet identified and it is a possibility that the association signal is 












































In this thesis I have described experiments designed to study the biological functions 
of NPAS3 and other transcription factors in the hope that the results would help our 
understanding of its role in mental illness. 
 
In order to pinpoint the location of NPAS3 activity in the brain and identify the 
biological processes NPAS3 regulates relevant to mental illness, I carried out 
Immunofluorescence on mouse brain sections and microarrays of NPAS3 over-
expressing cell lines. 
 
Strong Npas3 expression was seen in the hippocampal subgranular zone - the site of 
adult neurogenesis. It is found to be colocalised with Dcx, not other neurogenesis 
makers, in the dentate gyrus. NPAS3 and the SOX family of transcription factors 
shared many target genes suggesting overlapping neuro-developmental roles. 
Glycolytic and hypoxia-response genes were significantly enriched in the set of 
NPAS3 down-regulated genes. Additionally, in the circadian condition, NPAS3 
activity was shown to be sensitive to circadian time-point and protein truncation. 
 
Here, in the discussion chapter, I want to talk about the methods used, the 






7.1 Why a HEK293 cell line was used in my microarray studies 
The use of an over-expression model in the human epithelial kidney HEK293 cell 
line may not fully represent a transcription factor’s role in a neuronal context but I 
believe that, in addition to the convergence of transcriptional and metabolic findings 
discussed below, three observations suggest the data are biologically relevant. Firstly, 
there is a consistency of target gene sets between different transcription factors, 
which suggests technical quality and biological relevance. Our microarray data 
matched the evolutionary distance between the SOX genes. For example, closely 
related SOX D members (SOX5 and SOX6) showed more internal overlap that with 
SOX E members (SOX9 and SOX10). If the data in HEK293 cells were just artefacts, 
these would not be expected. Secondly, the neuronal-exclusivity, or enrichment in 
comparison to kidney, of many up-regulated NPAS3/SOX targets such as VGF, 
NEFH, CHGA, GALR2, GADD45B, and VASN suggests that the HEK293 cellular 
phenotype does not preclude the expression of CNS genes. Indeed, there is some 
speculation (http://www.fda.gov/ohrms/dockets/ac/01/transcripts/3750t1_01.pdf) 
from the laboratory that originally derived the cell line in 1973 that HEK293 cells 
might actually be of neuronal origin because of the expression of many neuronal 
markers (including NEFH mentioned above) and because neuronal cells are readily 
transformed by the adenovirus 5 used.  Thirdly, as our experiments involve 
transfecting a gene of interest and then analyzing the expression profile, the 
behaviour of the cell itself is not of interest. It is well known that HEK293 cell is a 
particularly good model for this kind of experiment (Malagon et al., 2009; Tominaga, 
2010).  
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7.2 Why not use a stem cell model to look at the neurodevelopmental 
role of NPAS3? 
Human adult neuronal stem cells originated from hippocampus might be a good cell 
model to clarify the change in adult hippocampal neurogenesis in response to NPAS3 
or SOX11. However, the progeny of stem cell division that normally undergo a 
strictly limited number of replication cycles in vitro  and the efficiency of 
neurosphere transfection are very low (Doetsch et al., 2002). The small number of 
cells makes the synthesis of microarray probe very difficult. Therefore, it is very 
difficult to obtain a set of labelled cRNA with high RIN value from neural stem cell.  
 
Furthermore, the gene expression environment provided by human neuronal stem 
cells is still quite different from in vivo, as neural stem cells change properties in 
culture. The neurosphere-derived cells do not behave as stem cells when transplanted 
back into the brain (Marshall et al., 2006).  Based on all these reasons, HEK293 cells 
were chosen to be used in our studies. The approach offers a simple, high-throughput 










7.3 NPAS3 interacts with several SOX members 
Doublecortin (Dcx) is a neurogenesis marker which is expressed in newly formed 
neurons between the timing of their birth and final maturation (Brown et al., 2003).  
Sox11 is strictly expressed in Dcx-expressing, non-committed precursors and 
immature cells in the neurogenic area of adult brain, but not with Sox2-expressiong 
cells (Haslinger et al., 2009). In this study, Npas3 was also found to be colocalised 
with Dcx in cells with a differentiating morphology in the adult mouse hippocampus. 
Expression patterns of NPAS3 and SOX11 in the Dcx-expressing cells suggest that 
these two factors may exert their function during the same stage of neurogenesis. 
 
SOX D and SOX E members are involved in the regulation of the later stage of adult 
neuogenesis. SOX5 is involved in the regulation of neurogenesis by controlling cell 
cycle progression in neural progenitors (Martinez-Morales et al., 2010).  Another 
SOX gene studied, SOX9, has been shown to be important for differentiation of SVZ 
stem cell into neurons through miR-124 mediation (Cheng et al., 2009). In addition, 
mRNA of SOX10, a highly similar transcriptional factor to SOX9, was reduced in 
the hippocampus and anterior cingulated cortex of schizophrenia patients (Dracheva 
et al., 2006).  
 
Based on this information, I hypothesise that SOXD, SOXE, SOX11 and NPAS3 
exert their functions at similar timing of neurogenesis, probably after the birth of 
newly formed neurons and during their final maturation. As transcriptional regulators, 
whether there are any interactions between these genes. Thus, microarray studies 
were carried out to investigate the overlaps of the regulatory profile of these 
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transcription factors. We demonstrated that NPAS3 participates in a neuro-
developmental regulatory network overlapping and directly interacting with the SOX 
transcription factor family. The identification of multiple targets of these 
transcription factors should clarify their regulatory roles in embryonic and adult 
neurogenesis - processes that seem to correlate with the risk of depression and 
psychosis (Kempermann et al., 2008). We propose that the overlap between NPAS3 
and SOX5/6 target genes may reflect their activities downstream of the proliferative 




7.4 Altered metabolite levels in brain tissue from Npas3 knockout 
mice 
We collaborated with Lynsey MacIntyre and Dr. David Watson at Strathclyde 
University and Dr. Steven Clapcote at Leeds University to investigate metabolic 
changes in the brain of Npas3 (-/-) mice using high-resolution mass spectrometry-
based metabonomic analysis. This work is not directly part of my thesis – it is 
included in a collaborative paper submitted for publication on which I am joint first 
author (Sha, submitted) - but produced data that are highly relevant to my microarray 
analysis which I will discuss now. 
 
Four half-brains from homozygote knockout (KO) and four half-brains from wild-
type littermates were homogenised and extracted using solvents and then separated 
and identified using a Finnigan LTQ-Orbitrap fitted with a Surveyor HPLC pump. 
Many cellular metabolites showed changed levels in the knockout brain tissue. 
Decreased levels of dihydroxyacetone phosphate/glycerone phosphate and octulose-
1,8-bisphosphate in the KO (6% and 5% of wild-type levels, respectively) and 
increased levels of NAD+, cystathione and dTDP-glucose/galactose (12.4-, 3.7- and 
3.4-fold increases, respectively) were found in this study (Appendix table S6 a-d).  
 
It is very interesting that there is a large (over 12-fold) increase in the oxidised form 
of the coenzyme nicotinamide adenine dinucleotide (NAD+). This may indicate a 
slow-down in glycolysis rate (which produces the reduced form, NADH) or 
abnormally oxidative conditions in the cell. UDP-glucose/galactose, were increased 
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in knockout brain (TDP-glucose/-galactose level changes might be similarly 
explained), which indicates that ineffective glycolysis is possibly resulting in glucose 
build-up and storage as glycogen. In the same way, the altered concentrations of 
Sedoheptulose and Octulose-1,8-bisphosphate may indicate that ineffective 
glycolysis is impacting on the pentose phosphate pathway which commences with 
Glucose-6-phosphate. The decreases in Fructose 1,6-bisphosphate and 
Dihydroxyacetone Phosphate (DHAP) directly suggest glycolysis abnormalities. 
Further speculation indicated that there may be a direct link between DHAP decrease 
and the observed increase in another metabolite, Glycerol-3-Phosphate (G-3-P). To 
recycle NADH to NAD+ while simultaneously transferring the reducing power to the 
oxidative phosphorylation process within the interior of the mitochondrion, the 
glycerol-3-phosphate shuttle is employed at the outer mitochondrial membrane. This 
converts DHAP and NADH into G-3-P and NAD+ , catalysed by cytosolic G-3-P 
Dehydrogenase (GPD1); with the reverse process catalysed by mitochondrial GPD2 
generating reduced FADH within the mitochondrial matrix for subsequent energy 
production. A decrease in the efficiency of the reverse reaction (perhaps due to 
mitochondrial dysfunction) might contribute to shuttle failure and the altered levels 
of DHAP, G3P and NAD+ observed in knockout brain. Also correlated with low 
DHAP were reduced levels of lactoyl glutathione which can be formed from DHAP 
via methylglyoxal.  
 
The transcriptional inhibition of argininosuccinate synthase (ASS1) expression by 
NPAS3 over-expression was mirrored by significant changes in its substrates L-
citrulline (increased) and aspartate (decreased) in Npas3 knockout mice. ASS1 
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deficiency causes classic citrullinemia (MIM #215700) which can present with 
manic episodes and psychosis in adult patients (Ikeda et al., 2001). 
 
There is a high consistency between the metabolic findings in the NPAS3 
overexpression cells (microarray analysis) and knockout mouse brain (mass 
spectrometry analysis). Genes in the glycolysis pathway have been switched off in 
the NPAS3 overexpressed cells. This implicates that in the Npas3 (-/-) mice brain; 
the glycolysis pathway might be switched on (activated). In the Npas3 (-/-) mice 
brain, concentrations of upstream compounds of glucose-6-p are higher than normal 
condition. But as the genes which control the downstream of glucose-6-p in the 
glycolysis pathway are activated due the loss of Npas3, the downstream compounds, 
fructose-1,6-bisP and dihydroxyacetone-p, in the glycolysis pathway are metabolized 
much more quickly than normal condition. 
 
Pyruvate produced by glycolysis is transported across the inner mitochondrial 
membrane into the matrix and formed CO2 and acetyl-CoA and NADH (Voet, 2006). 
The acetyl-CoA is the substrate for the TCA cycle (also called Krebs cycle). The 
enzymes of the TCA cycle are located in the mitochondrial matrix, except the 
succinate dehydrogenase, which is a part of ComplexII of the inner mitochondria 
membrane (King et al., 2006). In the Npas3 (-/-) mice brain, concentrations of α-
Ketoglutarate and Succinate, both are the compounds of TCA cycle, are higher. This 
implies that the TCA cycle in the mitochondria of brain might be accelerated due to 
the loss of Npas3. Whether the abnormal energy production from the TCA could 
affect other aspects of mitochondrial function is not yet determined. Is the abnormal 
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energy metabolism in the mitochondria is associated with the lack of neurogenesis in 
the Npas3 (-/-) mice? 
 
However, the metabolic study by the mass spectrometry analysis is based on the 
whole brain (not just subgranular zone). In a whole organism, the effects of loss of 
Npas3 might be modified by homeostasis, energy control by other factors etc. Thus, 




Figure 7.1 Three metabolic pathways with coincident findings from the 
transcriptomic and metabonomic analyses.  
These were glycolysis, the tricarboxylic acid (Citric acid/Krebb’s) cycle and the urea 
cycle. In each case the enzyme or regulatory protein is listed in italics with transcript 
fold down-regulation upon NPAS3 over-expression shown in brackets. Heavy black 
arrows indicate the direction by which metabolite abundance is changed in the 
knock-out mouse brain. The Glycerol-3-phosphate shuttle uses the interconversion of 
DHAP and G-3-P to transfer reducing power from cytosolic NADH to mitochondrial 
FADH2. One interpretation of the metabolic changes in knockout brain invokes a 
reduction in mitochondrial GPD2 function resulting in reducled shuttle efficiency 
and the observed directional concentration changes of DHAP, G-3-P and NAD+. 
Emboldened –P indicates Phosphate. 
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7.5 Comparing my NPAS3 findings with newly published data. 
Recently Pieper et al. (Pieper et al., 2010) identified P7C3, an aminopropyl carbazole, 
which has proneurogenic activity by protecting newborn neurons from apoptosis. 
Their results are summarised in Figure 7.4 A. Prolonged administration of P7C3 
increased Dcx+ neurons in mouse hippocampus. In collaboration with Wang et al., 
they showed that P7C3 protected mitochondrial membrane integrity, thus preventing 
apoptosis. An intrinsic pathway leading to apoptosis emanates from mitochondria 
(Liu et al., 1996; Yang et al., 1997). NPAS3 (-/-) mice were reported with devoid of 
hippocampal neurogenesis and display malformation and electrophysiological 
dysfunction of the dentate gyrus (Erbel-Sieler et al., 2004; Pieper et al., 2005) 
(Figure 7.2 A). Prolonged administration of P7C3 to Npas3 (-/-) mice corrected these 
deficits by normalising levels of apoptosis of newborn hippocampal neurons (Pieper 
et al., 2010) 
 
In this PhD project, Thirty-six of the 282 up-regulated genes (corrected 
hypergeometric p-value = 2.07 X 10-8) were either transcription factors or DNA-
binding proteins with regulatory function (Figure 7.2 B). Combined with Pieper’s 
finding and our finding of the colocalization with Dcx in the dentate gyrus, we 
hypothesis that NPAS3 is involved in the regulation of neurogenesis at the stage of 
maturation and survival. 
 
Glycolysis pathways were disturbed by altering NPAS3 activity. The increased levels 
of 2-Oxoglutarate/α-Ketoglutaric acid and Succinate in Kreb’s cycle (TCA cycle), 
which is within mitochondria, were found in Npas (-/-) mouse brains. Linking with 
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the finding of Pieper et al. that P7C3 acts on deficient mitochondrial function and 
corrects the lack of hippocampus neurogenesis in Npas (-/-) mouse, I suppose that in 
the Npas3 (-/-) mice, there might be some connection between neurogenesis and 






Figure 7.2 Comparison of my NPAS3 findings with Andrew Pieper’s recent result.  
A: P7C3 increase neurogenesis by protecting new born neurons from apoptosis. 
P7C3 also can correct the malformation and electrophysiological dysfunction of the 
dentate gyrus in Npas3 (-/-) mice. B: Several transcription factors and genes involved 
in neurogenesis were upregulated in NPAS3 overexpression cells. Many genes in 
glycolysis pathways were also down regulated in NPAS3 overexpressing cells. 
Compounds involved in glycolysis, TCA cycle (within mitochondria), ‘G-3-P 








7.6 A link between metabolism and circadian rhythms. 
I think it is important to investigate the linkage of metabolic aspect of NPAS3 and 
effect of circadian rhythms on the regulatory prolife of NPAS3. There is ample 
experimental evidence suggesting that the circadian clock controls metabolic activity 
and metabolism feeds back to impinge upon the rhythm (Roenneberg and Merrow, 
1999). There is much evidence for a functional link between metabolism and 
circadian rhythms in the brain. First, certain genes encoding metabolic enzymes and 
transport systems for energy metabolites are under circadian control, including 
glycogen phosphorylase (Harley and Rusak, 1993; Harley et al., 2001), cytochrome 
oxidase, lactate dehydrogenase (Rutter et al., 2001) and the monocarboxylate 
transporter 2 (MCT2). Secondly, glucose uptake in the SCN and other brain areas 
fluctuates in a circadian rhythm (Newman and Hospod, 1986; Schwartz and Gainer, 
1977; Shibata and Moore, 1988). Finally, the concentration of ATP exhibits marked 
circadian fluctuation (Yamazaki et al., 1994). 
 
Astrocytes can regulate the balance between neuronal activity and energy substrate 
uptake and utilization at the cellular level (Bergles and Jahr, 1998). Magistretti and 
Pellerin developed a model to explain how neural activity induces glucose uptake 
and glycolysis in astrocytes (Figure 7.3). Glutamate, which is from neuronal activity, 
can be absorbed by astrocytes via glutamate transporters and with concomitant Na+ 
transmission. Increased Na+ concentrations in the cell activates the astrocytic 
Na+/K+-ATPase, which can further activate glucose uptake and glycolysis (Pellerin 
and Magistretti, 1994; Pellerin and Magistretti, 1997).  Lactate, the glycolysis 
product, is shuttled into neurons through two monocarboxylate transporters MCT1 
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and MCT2 to provide energy for these active neurons (Pellerin et al., 1998). 
Strikingly, it was reported that the expression of a fly MCT-like gene is in a 




Figure 7.3 Model for electrical activity-induced change in neuronal redox status. An 
increase in synaptic glutamate stimulates glycolytic flux and lactate export in 
astrocytes. The monocarboxylate transporter, MCT2, facilitates neuronal uptake of 
lactate, which increases the NADH:NAD ratio via the lactate dehydrogenase (LDH) 









The energy metabolites induced by neuronal activity possibly feed back on to the 
circadian rhythm. This was supported by two observations: first, Rats injected with 
2-DG (2-deoxyglucose), which inhibits glucose utilization, have a blocked light-
induced phase shift (Challet et al., 2000; Challet et al., 1999). Second, caloric 
restriction can entrain the rhythm of peripheral oscillators (Challet et al., 2000; 
Damiola et al., 2000; Stokkan et al., 2001).  
 
This is related to what we see in our microarray results that genes involved in 
glycolysis were negatively regulated in cells over-expressing NPAS3. Also disrupted 
metabolic control, including glycolysis, was discovered in the brains of Npas3 (-/-) 
mice by mass spectrometry (Sha et al. submitted). The ternary plot results (Figure 5.4 
b) also show that FLNPAS3 mainly exerts an inhibitory regulation on the circadian 
genes at +12 hours after circadian rhythm induction but not after +24 hours. Based 
on the model developed by Magistretti and Pellerin (Pellerin and Magistretti, 
2004),we support the hypothesis that NPAS3 might inhibit the utilization of glucose 
which then blocks the normal circadian rhythm in the cell. There might be another 
possibility behind the phenomenon of the altered circadian in the HEK293 cells.  
Many genes controlling the circadian rhythm are members of the bHLH transcription 
family and they might have the properties of binding to NPAS3 or NPAS3’s partner 
(such as BMAL)(Nievergelt et al., 2006). Therefore, there is an opportunity for these 
factors to interact with each other or to sequester common binding partners. These 
findings not only link psychiatric illness into the cycle composed of neuronal activity, 
energy metabolism and circadian rhythm, but also suggest the underlying mechanism 
at the molecular level. 
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7.7 Limitations of my work and Future directions worthy of study 
This study of disease gene function in cell and animal models provides valuable 
clues to the understanding of the pathology of psychiatric illness. However, 
confirmation of these findings in patients will be necessary. NPAS3-mediated 
changes in metabolic activity may have a direct impact on brain imaging techniques 
such as functional magnetic resonance imaging or positron emission tomography that 
are sensitive to glucose and oxygen consumption. In the context of psychiatric 
patient studies, such imaging data may be a reflection of primary metabolic failures 
rather than the intended indirect measurement of regional neuronal activity. In my 
PhD project, this kind of experiments can not be carried out due to the limited time 
and funding.  
 
Our study suggests that many NPAS3 regulated genes are involved in adult 
neurogenesis. Disturbance in the metabolic pathways can also affect the cell growth. 
Investigation of the roles of NPAS3 and SOX members in adult neural stem cells is 
an indispensable stage to understand and characterise how these genes contribute 
adult neurogenesis. Although we tried to isolate primary mouse hippocampus 
progenitor cells and purchased human hippocampus stem cell from European 
Collection of Cell Cultures (ECACC), functional studies on these models were not 





7.8 Relating our observations to the known biology of psychiatric 
disorders 
Although metabolic disturbance, including weight gain, insulin sensitivity and 
increased risk of diabetes (Obesity, 2004), is often found in psychiatric patients, this 
metabolic syndrome has often been attributed to side effects of the medical 
treatments (such as typical and atypical antipsychotic drugs) rather than inherent 
deficits. Several genes involved in glycolysis do appear to be involved in the 
response to drug therapies for psychiatric disorders.  A gene expression study of 
lithium-regulated transcriptional changes on mice brain reveals that ALDOC was one 
of the top up-regulated genes (McQuillin et al., 2007). Olanzapine, one of the 
antipsychotic drugs, has been shown to increase ALDOA, ENO1, ENO2, PGAM1 
and GAPDH protein expression (Ma et al., 2009a).  
 
However, inherent vulnerability also contributes to metabolic disturbance in 
psychiatric diagnosis (van Winkel et al., 2008). Accumulating evidence suggests that 
glycolytic dysfunction (Martins-de-Souza et al.), mitochondrial failure, and oxidative 
stress (Do et al., 2009) contribute to disturbed metabolism in schizophrenia and 
bipolar disorder. Significant changes in multiple glycolytic enzyme levels were 
identified in peripheral blood monocytes of schizophrenia patients who were 
receiving no treatment in a recent proteomic analysis (Herberth et al., ; Herberth et 
al., 2010). My results show that metabolic pathways, including glycolysis, are 
disturbed by NPAS3. These NPAS3-mediated metabolic changes support the view 
that inherent deficits may also contribute to metabolic dysregulation. 
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It is still not clear whether risk of psychiatric illness contributed by NPAS3 is 
through deficits in the process of neurogenesis or metabolic regulation, or both are 
required for full expression of illness. We suggest that NPAS3 metabolism defects 
might have a particularly detrimental effect on labile new neurons produced in the 
fluctuating perfusion conditions present in the vascularised neurogenic niche 
(Nikolova et al., 2007; Palmer et al., 2000; Pereira et al., 2007). Hence, the 
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